https://www.tevapharm.com/our-company/corporate-governance/board-of-directors/dr-sol-j-barer/2025-03-17T13:54:17+00:00weekly0.5https://www.tevapharm.com/our-company/corporate-governance/board-of-directors/richard-francis/2025-07-17T09:21:52+00:00yearly0.5https://www.tevapharm.com/our-company/corporate-governance/board-of-directors/rosemary-a-crane/2025-07-17T09:19:55+00:00yearly0.5https://www.tevapharm.com/our-company/corporate-governance/board-of-directors/amir-elstein/2025-09-01T09:33:56+00:00monthly0.5https://www.tevapharm.com/our-company/corporate-governance/board-of-directors/geral-m-lieberman/2025-07-17T09:23:26+00:00yearly0.5https://www.tevapharm.com/our-company/corporate-governance/board-of-directors/roberto-a-mignone/2025-09-01T09:35:00+00:00monthly0.5https://www.tevapharm.com/our-company/corporate-governance/board-of-directors/dr-perry-d-nisen/2025-07-17T09:24:06+00:00yearly0.5https://www.tevapharm.com/our-company/corporate-governance/board-of-directors/prof-ronit-satchi-fainaro/2025-07-17T09:22:30+00:00weekly0.5https://www.tevapharm.com/our-company/corporate-governance/board-of-directors/prof-varda-shalev/2025-07-17T09:22:12+00:00monthly0.5https://www.tevapharm.com/our-company/corporate-governance/board-of-directors/janet-s-vergis/2025-07-17T09:22:54+00:00yearly0.5https://www.tevapharm.com/our-company/corporate-governance/board-of-directors/tal-zaks/2025-07-17T09:19:40+00:00yearly0.5https://www.tevapharm.com/our-company/corporate-governance/teva-corporate-officers/richard-francis/2025-07-17T09:06:20+00:00weekly0.5https://www.tevapharm.com/our-company/corporate-governance/teva-corporate-officers/richard-daniell/2025-07-17T09:06:39+00:00monthly0.5https://www.tevapharm.com/our-company/corporate-governance/teva-corporate-officers/christine-fox/2025-11-04T08:23:55+00:00monthly0.5https://www.tevapharm.com/our-company/corporate-governance/teva-corporate-officers/eric-hughes/2025-07-17T09:08:45+00:00monthly0.5https://www.tevapharm.com/our-company/corporate-governance/teva-corporate-officers/placid-jover/2025-07-17T09:06:57+00:00monthly0.5https://www.tevapharm.com/our-company/corporate-governance/teva-corporate-officers/eli-kalif/2025-03-17T13:49:59+00:00monthly0.5https://www.tevapharm.com/our-company/corporate-governance/teva-corporate-officers/david-mcavoy/2025-07-17T09:09:31+00:00monthly0.5https://www.tevapharm.com/our-company/corporate-governance/teva-corporate-officers/mark-sabag/2025-07-17T09:08:10+00:00monthly0.5https://www.tevapharm.com/our-company/corporate-governance/teva-corporate-officers/matthew-shields/2025-07-17T09:07:37+00:00weekly0.5https://www.tevapharm.com/our-company/corporate-governance/teva-corporate-officers/nir-baron/2025-07-17T09:07:17+00:00monthly0.5https://www.tevapharm.com/our-company/corporate-governance/teva-corporate-officers/kathleen-veit/2025-07-17T09:08:25+00:00monthly0.5https://www.tevapharm.com/our-company/corporate-governance/corporate-governance-documents/efpia-disclosure/2025-07-17T09:17:34+00:00monthly0.5https://www.tevapharm.com/our-company/corporate-governance/board-of-directors/chen-lichtenstein/2025-09-01T09:34:49+00:00yearly0.5https://www.tevapharm.com/our-company/corporate-governance/teva-corporate-officers/evan-lippman/2025-04-01T06:17:59+00:00weekly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-host-conference-call-to-discuss-first-quarter-2025-financial-results-at-8-a.m.-et-on-may-7-20252025-06-16T09:17:52+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-releases-q1-2025-aide-memoire/2025-07-17T11:43:37+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/new-data-strengthens-tevas-schizophrenia-portfolio-including-phase-3-solaris-trial-survey-results-demon/2025-07-17T11:45:15+00:00monthly0.5https://www.tevapharm.com/science/innovative-therapeutic-areas/respiratory/2025-10-29T16:14:57+00:00monthly0.5https://www.tevapharm.com/science/innovative-therapeutic-areas/migraine/2025-10-29T16:14:26+00:00monthly0.5https://www.tevapharm.com/science/innovative-therapeutic-areas/mental-health/2025-10-29T16:14:09+00:00monthly0.5https://www.tevapharm.com/science/innovative-therapeutic-areas/movement-disorders/2025-10-29T16:14:39+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/moodys-investor-services-upgrades-teva-amid-continued-success-of-pivot-to-growth-strategy/2025-10-28T17:14:32+00:00monthly0.5https://www.tevapharm.com/our-impact/healthy-future-report/healthy-future-highlights-infographic/2025-10-30T10:07:36+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/tevas-2024-healthy-future-report-highlights-sustainability-progress-including-surpassed-targets-linked-/2025-10-29T15:35:19+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/cold-water-swimming-anxiety-benefits/2025-11-20T11:09:48+00:00weekly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/managing-fatigue-during-cancer-treatment/2025-11-20T11:10:54+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/neurological-conditions-take-so-much-teva-neuroscience-expertise/2025-10-28T11:59:25+00:00weekly0.5https://www.tevapharm.com/science/innovative-therapeutic-areas/huntingtons-disease-hd/2025-10-29T16:10:39+00:00weekly0.5https://www.tevapharm.com/science/innovative-therapeutic-areas/tardive-dyskinesia-td/2025-10-30T13:19:02+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/migraine-and-sensory-overload/2025-11-20T11:11:36+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/caregiving-doesnt-stop-when-cancer-treatment-does/2025-11-20T11:12:22+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/stay-active-with-heart-disease/2025-11-20T11:14:05+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-host-innovation--strategy-day-on-thursday-may-29-in-new-york-city/2025-10-29T15:23:14+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-ninth-consecutive-quarter-of-growth-in-q1-2025-with-key-innovative-medicines-growing-~40-2/2025-10-28T17:50:04+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/managing-asthma-through-lifestyle-changes/2025-11-20T11:14:44+00:00weekly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/mental-resilience-with-cystic-fibrosis/2025-11-20T11:15:21+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-increase-of-the-maximum-tender-amount-of-its-debt-tender-offer-and-increases-to-pool-tende/2025-10-28T17:44:45+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-biolojic-design-initiate-ind-enabling-studies-of-bd9-a-multibody-designed-to-explore-the-treatm/2025-10-28T17:20:42+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-jefferies-global-healthcare-conference-and-goldman-sachs-global-healthcare-conference-/2025-10-29T15:23:42+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-celiac-disease-candidate-granted-fast-track-designation-by-us-fda/2025-10-28T17:46:51+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reaffirms-pivot-to-growth-strategy-progress-with-launch-of-acceleration-phase-at-2025-innovation-a/2025-10-28T17:48:38+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-presents-latest-schizophrenia-portfolio-data-including-real-world-outcomes-with-uzedy-risperidone/2025-10-30T14:04:46+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/new-data-from-teva-shows-substantial-rates-of-undertreated-tardive-dyskinesia-in-long-term-care-settings-/2025-10-28T17:15:11+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-early-tender-results-of-its-debt-tender-offer-increase-to-tender-pool-caps-and-total-maxi/2025-10-28T17:27:01+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/managing-tardive-dyskinesia-and-anxiety/2025-11-20T11:16:12+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/tevaannounceslaunchof$2000000000-equivalent-offeringofsenior-notes/2025-10-29T15:34:59+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/tevaannounces$2000000000-equivalent-debttenderoffersfor-notes-due-2026-2031/2025-10-29T15:27:03+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/fitch-ratings-agency-upgrades-teva-rating-to-bb-recognizing-successful-execution-of-its-pivot-to-growth-/2025-10-28T17:13:44+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-successful-upsizing-and-pricing-of-$2300000000-equivalent-senior-notes-proceeds-to-r/2025-10-28T17:46:28+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-alvotech-announce-fda-approval-of-interchangeability-for-selarsdi-ustekinumab-aekn-with-stela/2025-10-28T17:19:35+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/esg-report-2024-healthy-future-we-want-to-see/2025-07-17T09:46:05+00:00weekly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-pricing-and-early-acceptance-results-of-its-debt-tender-offer/2025-10-28T17:45:46+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/the-future-of-medicine-is-now-8-ways-teva-is-accelerating-healthcare-innovation-through-ai-advanced-devices-and-global-collaboration/2025-10-30T13:14:46+00:00monthly0.5https://www.tevapharm.com/our-company/our-values/teva-leadership-principles/2025-06-19T18:42:32+00:00weekly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-fosun-pharma-enter-into-a-strategic-partnership-to-develop-novel-anti-pd1-il2-therapy-tev-56278/2025-10-28T17:21:30+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/driving-with-schizophrenia/2025-11-20T11:16:54+00:00weekly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/erica-crompton/2025-11-20T13:46:59+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/migraine-dating-red-flags/2025-11-20T11:18:01+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-host-conference-call-to-discuss-second-quarter-2025-financial-results-at-8-a.m.-et-on-july-30-202025-10-30T14:08:26+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/final-data-from-tevas-pearl-real-world-study-reinforce-the-long-term-effectiveness-of-ajovy-fremanezum/2025-10-28T17:12:59+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-releases-q2-2025-aide-memoire/2025-10-28T17:49:02+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/balancing-hope-reality-expectations-as-caregivers/2025-11-20T11:18:37+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/loneliness-epidemic-how-to-find-connection/2025-11-20T11:19:25+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/mindfulness-meditation-migraine-help/2025-11-20T11:20:05+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/teva-argentina-management-team/2025-07-17T11:22:54+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/migraine-allodynia-sleep-issues/2025-11-20T11:20:50+00:00weekly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/diagnosed-with-schizophrenia-what-i-wish-id-known-then/2025-11-20T11:22:49+00:00weekly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/sarah-merritt-ryan/2025-11-20T14:41:44+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/tevas-innovative-portfolio-fuels-10th-consecutive-quarter-of-growth-in-q2-2025-increases-2025-revenue-o/2025-10-29T15:36:44+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/migraine-unpredictability-affects-mental-health/2025-11-20T11:24:17+00:00weekly0.5https://www.tevapharm.com/news-and-media/feature-stories/q2-2025-results-powered-podcast/2025-10-28T12:00:38+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/fda-approves-expanded-indication-for-ajovy-fremanezumab-vfrm-the-first-anti-cgrp-preventive-treatment/2025-10-28T17:12:13+00:00weekly0.5https://www.tevapharm.com/news-and-media/feature-stories/teva-rd-innovation-traits/2025-08-20T12:16:55+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/Shaping-the-future-of-medicine/2025-10-28T11:31:14+00:00weekly0.5https://www.tevapharm.com/news-and-media/feature-stories/Manufacturing-Modernization-trends-Greta-Pusch/2025-10-28T11:24:03+00:00weekly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-fda-approval-and-launch-of-generic-saxenda-liraglutide-injection--first-generic-glp-1-/2025-10-28T17:43:25+00:00weekly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-morgan-stanley-global-healthcare-conference-and-bank-of-america-global-healthcare-conf/2025-10-29T15:24:09+00:00weekly0.5https://www.tevapharm.com/news-and-media/feature-stories/Teva-Developing-The-Next-Generation-Of-Medicine/2025-10-31T14:09:42+00:00weekly0.5https://www.tevapharm.com/your-career/our-people/preventative-care-at-teva/2025-10-30T14:36:21+00:00weekly0.5https://www.tevapharm.com/news-and-media/latest-news/tevas-emrusolmin-granted-u.s.-fda-fast-track-designation-for-treatment-of-multiple-system-atrophy2025-10-29T15:36:03+00:00weekly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/moving-forward-after-psychosis/2025-11-20T11:25:34+00:00weekly0.5https://www.tevapharm.com/news-and-media/latest-news/patients-taking-austedo-xr-deutetrabenazine-extended-release-tablets-reported-symptom-improvement-and-/2025-10-28T17:18:29+00:00weekly0.5https://www.tevapharm.com/news-and-media/latest-news/new-long-term-safety-data-from-the-completed-phase-3-solaris-trial-support-the-potential-of-olanzapine-la/2025-10-28T17:17:48+00:00weekly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/migraine-management-mental-health-mindfulness/2025-11-20T11:26:15+00:00weekly0.5https://www.tevapharm.com/news-and-media/feature-stories/antibody-generation-david-laine/2025-10-28T16:05:53+00:00weekly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-host-conference-call-to-discuss-third-quarter-2025-financial-results-at-8-a.m.-et-on-november-5-2025-10-29T15:22:46+00:00weekly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-releases-q3-2025-aide-memoire/2025-10-28T17:49:36+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-update-sale-tapi/2025-10-29T15:26:25+00:00weekly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-host-conference-call-to-discuss-data-from-the-completed-phase-3-solaris-trial-for-olanzapine-lai-/2025-10-28T17:50:29+00:00weekly0.5https://www.tevapharm.com/news-and-media/feature-stories/matt-schizophrenia-journey/2025-10-24T07:17:35+00:00weekly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/managing-stress-with-tardive-dyskinesia/2025-11-20T11:28:06+00:00weekly0.5https://www.tevapharm.com/news-and-media/feature-stories/Matt-schizophrenia-journey-carer/2025-10-24T07:17:06+00:00weekly0.5https://www.tevapharm.com/news-and-media/feature-stories/td-and-schizophrenia-ilan-melnick-discussion/2025-10-15T07:04:57+00:00weekly0.5https://www.tevapharm.com/news-and-media/latest-news/fda-approves-expanded-indication-for-uzedy-risperidone-extended-release-injectable-suspension-as-a-tre/2025-11-09T08:04:46+00:00weekly0.5https://www.tevapharm.com/news-and-media/feature-stories/Melissa-TD-Journey/2025-10-24T07:16:09+00:00weekly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/benefits-nature-mental-health/2025-11-20T11:28:57+00:00weekly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/eating-well-support-mental-health-schizophrenia/2025-11-20T11:29:55+00:00weekly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/how-cats-help-coping-with-schizophrenia/2025-11-20T12:20:11+00:00weekly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/music-impact-on-schizophrenia-mental-wellbeing/2025-11-20T12:22:00+00:00weekly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-prestige-biopharma-enter-license-agreement-for-tuznue-commercialization-in-europe/2025-10-20T20:35:03+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/rediscovering-yourself-after-psychosis-and-cognitive-impairment/2025-11-20T12:23:11+00:00weekly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/how-anxiety-may-influence-auditory-hallucinations/2025-11-20T12:23:56+00:00weekly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-ubs-global-healthcare-conference-and-jefferies-london-healthcare-conference-in-novembe/2025-10-31T20:35:04+00:00weekly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-kicks-off-the-other-td-to-raise-awareness-of-tardive-dyskinesia-td-with-support-from-pro-footba/2025-11-03T13:10:09+00:00weekly0.5https://www.tevapharm.com/news-and-media/latest-news/tevas-innovative-portfolio-drives-11th-consecutive-quarter-of-growth-in-q3-2025-increases-2025-outlook-/2025-11-05T12:05:23+00:00weekly0.5https://www.tevapharm.com/news-and-media/feature-stories/q3-business-highlights-at-a-glance/2025-11-06T12:56:39+00:00daily0.5https://www.tevapharm.com/news-and-media/latest-news/austedo-deutetrabenazine-tablets-and-austedo-xr-deutetrabenazine-extended-release-tablets-demonstra/2025-11-07T23:05:05+00:00weekly0.5https://www.tevapharm.com/news-and-media/feature-stories/Teva-Implementing-New-Augmented-Reality-Solution/2025-11-12T13:00:37+00:00weekly0.5https://www.tevapharm.com/news-and-media/feature-stories/amr-awareness-week-2025/2025-11-17T13:10:21+00:00weekly0.5https://www.tevapharm.com/news-and-media/feature-stories/teva-rise-healthcare-innovation-and-technology/2025-11-19T13:10:02+00:00weekly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-launches-rise-a-global-open-innovation-platform-to-accelerate-ai-industry-4.0-smart-manufacturing2025-11-19T13:05:05+00:00weekly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-8th-annual-evercore-healthcare-conference-the-piper-sandler-37th-annual-healthcar/2025-11-21T21:35:05+00:00daily0.5https://www.tevapharm.com/news-and-media/latest-news/teva-receives-european-commission-approvals-for-ponlimsi-denosumab-biosimilar-to-prolia-and-degevma-/2025-11-25T13:15:07+00:00daily0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/adhd-relationship-issues/2025-11-20T12:24:37+00:00monthly0.5https://www.tevapharm.com/science/innovative-therapeutic-areas/multiple-system-atrophy-msa/2025-10-30T14:29:17+00:00weekly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/recognizing-migraine-symptoms-in-children/2025-11-20T12:25:25+00:00monthly0.5https://www.tevapharm.com/teva-medical-information/report-a-side-effect-form/pspmr-form2/2025-06-24T06:33:03+00:00monthly0.5https://www.tevapharm.com/teva-medical-information/report-a-side-effect-form/patient-form/2025-06-24T06:33:15+00:00weekly0.5https://www.tevapharm.com/teva-medical-information/report-a-side-effect-form/teva-employee-form/2025-06-24T06:33:33+00:00monthly0.5https://www.tevapharm.com/teva-medical-information/report-a-side-effect-form/caregiver-form/2025-06-24T06:33:50+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-fda-filing-acceptance-for-ajovy-fremanezumab-in-pediatric-episodic-migraine-prevention/2025-10-28T17:43:52+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-samsung-bioepis-announce-biosimilar-epysqli-eculizumab-aagh-injectionnow-available-in-the-un/2025-10-28T17:23:03+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/caregiving-myths-that-stop-us-from-asking-for-help/2025-11-20T12:26:29+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/duvakitug-inflammatory-bowel-disease-crohns-colitis/2025-07-17T09:44:03+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/caregiving-for-parent-you-dont-get-along-with/2025-11-20T12:27:08+00:00weekly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/how-tardive-dyskinesia-impacts-daily-life/2025-11-20T12:31:00+00:00weekly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/how-trauma-affects-the-body/2025-11-20T12:32:11+00:00weekly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/visualization-for-better-health/2025-11-20T12:34:24+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/alvotech-and-teva-announce-filing-acceptance-ofu.s.-biologics-license-application-for-avt06a-proposed-2025-07-17T11:35:49+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-host-conference-call-on-february-24-2025-to-discuss-new-data-presented-for-duvakitug-anti-tl1a/2025-07-17T11:37:01+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/talk-therapy-help-psychosis-schizophrenia/2025-11-20T12:35:35+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-alvotech-announce-selarsdi-ustekinumab-aekn-injection-now-available-in-the-u.s2025-07-17T11:38:13+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-sanofi-present-new-positive-phase-2b-study-results-at-ecco-2025-reinforcingbest-in-class-potent/2025-06-26T13:48:27+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/teva-pharmaceuticals-careers-boomerang-coming-home/2025-07-17T10:04:30+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/huntingtons-disease-impact-on-relationships/2025-11-20T12:36:38+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-medincell-announce-fda-acceptance-of-supplemental-new-drug-application-for-uzedyr-risperidone/2025-06-26T13:46:57+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/2025-community-routes-access-to-mental-health-care-grants-awarded-to-clinics-in-alabama-mississippi-an/2025-07-17T11:42:57+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-agreement-to-divest-teva-takeda-its-business-venture-in-japan/2025-11-09T08:12:09+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/real-progress-comes-not-from-extraordinary-moments-but-from-the-everyday/2025-07-17T11:03:22+00:00weekly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/katarzyna--patryk/2025-11-20T14:22:58+00:00weekly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/navigating-schizophrenia-and-psychosis-with-my-son/2025-11-20T12:43:28+00:00weekly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-new-patient-access-program-with-direct-relief-to-provide-access-to-inhalers-for-uninsured-patients/2025-10-28T17:45:12+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-barclays-global-healthcare-conference-and-leerink-partners-global-healthcare-conferences/2025-10-30T14:10:16+00:00monthly0.5https://www.tevapharm.com/our-impact/healthy-future-report/healthy-future-infographics/2025-07-17T08:53:24+00:00monthly0.5https://www.tevapharm.com/our-impact/healthy-future-report/2023-esg-highlights-infographic/2024-11-16T00:44:46+00:00monthly0.5https://www.tevapharm.com/our-impact/economic-impact-report/economic-impact-infographic/2024-11-22T11:16:12+00:00monthly0.5https://www.tevapharm.com/our-impact/esg-progress-report-2020/2020-esg-highlights-infographic/2025-05-27T07:37:04+00:00monthly0.5https://www.tevapharm.com/our-impact/esg-progress-report-2021/2021-esg-highlights/2025-05-27T07:37:39+00:00monthly0.5https://www.tevapharm.com/teva-clinical-trials/clinical-trials-results/clinical-trials/2025-11-25T10:16:05+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/coping-with-chronic-illness-over-christmas/2025-11-20T12:44:14+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/bethany-chalmers/2025-11-20T13:31:43+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/the-day-i-became-aware-of-my-tardive-dyskinesia-symptoms/2025-11-20T12:46:02+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/clinical-research-study-trends-nagesh-thudi/2025-07-17T09:08:36+00:00weekly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-43rd-annual-j.p.-morgan-healthcare-conference2025-10-29T15:24:44+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results-and-2025-fina/2025-10-29T15:19:56+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-sanofi-announce-duvakitug-anti-tl1a-positive-phase-2b-results-demonstrating-best-in-class-pote/2025-11-09T08:10:54+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-presents-positive-efficacy-and-safety-data-of-ajovy-fremanezumab-for-the-prevention-of-episodic-m/2025-11-09T08:10:08+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-7th-annual-evercore-isi-healthconx-conference/2025-11-09T08:09:19+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-jefferies-london-healthcare-conference/2025-11-09T08:08:52+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-samsung-bioepis-enter-into-a-strategic-partnership-for-commercialization-of-epysqli-eculizumab/2025-10-28T17:25:16+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-collaboration-to-commercialize-formycons-biosimilar-candidate-to-eylea-aflibercept-in-/2025-10-28T17:26:06+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/teva-pharmaceuticals-careers-boomerang-employees/2025-07-17T10:03:19+00:00weekly0.5https://www.tevapharm.com/news-and-media/feature-stories/statistics-data-science-and-medical-writing-at-teva/2025-07-17T10:54:53+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/schizophrenia-stigma-shame-stereotypes-media-myths/2025-11-20T12:50:00+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/healthcare-trends-innovation-collaboration-konstantina-katcheves/2025-07-17T10:14:21+00:00weekly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/managing-heart-health-when-grieving/2025-11-20T12:50:54+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/teva-earns-equality-award-in-human-rights-campaign-foundations-corporate-equality-index/2025-10-28T16:12:33+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/alvotech-and-teva-announce-filing-acceptance-ofu.s.-biologics-license-applications-for-avt05a-proposed2025-10-28T16:16:15+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-delivers-second-consecutive-year-of-growth-announces-strong-financial-results-in-fourth-quarter-and/2025-10-28T17:47:17+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/medical-device-engineering-combination-products/2025-07-17T11:06:49+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/anosognosia-impaired-mental-illness-awareness/2025-11-20T13:16:46+00:00monthly0.5https://www.tevapharm.com/your-career/our-people/teva-health-care-trends/2025-07-17T07:05:26+00:00monthly0.5https://www.tevapharm.com/your-career/our-people/celebrating-120-years-of-teva/2024-11-16T00:30:56+00:00yearly0.5https://www.tevapharm.com/science/innovative-therapeutic-areas/schizophrenia/2025-07-17T07:43:48+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/caring-for-the-caregivers/caring-for-yourself-while-caring-for-others/2025-11-24T10:37:55+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/caring-for-the-caregivers/caregiver-handbook/2025-11-24T10:38:12+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/caring-for-the-caregivers/caregiver-tips-self-assessment-form/2025-11-24T10:38:28+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/caring-for-the-caregivers/caregiver-tips-doctor-visit/2025-11-24T10:38:45+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/caring-for-the-caregivers/3-powerful-self-care-habits-for-caregivers/2025-11-24T10:39:12+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/caring-for-the-caregivers/caregiver-advice/2025-11-24T10:39:27+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/caring-for-the-caregivers/caregiver-advice-life-change/2025-11-24T10:39:47+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/caring-for-the-caregivers/caregiver-burnout/2025-11-24T10:40:03+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/caring-for-the-caregivers/good-caregiver-advice/2025-11-24T10:40:43+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/adam-weitz/2025-11-20T13:27:06+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/alice-may-purkiss/2025-11-20T13:27:32+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/amy-marlow/2025-11-20T13:27:59+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/anna-crollman/2025-11-20T13:28:21+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/arthur-lazarev/2025-11-20T13:28:44+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/barbara-moore/2025-11-20T13:30:14+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/barbara-stensland/2025-11-20T13:30:47+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/beki-tovey/2025-11-20T13:31:16+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/birgit-bauer/2025-11-20T13:32:18+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/bryce-evans/2025-11-20T13:32:40+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/ciara-orourke/2025-11-20T13:39:04+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/claire-eastham/2025-11-20T13:39:29+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/crona-tansey/2025-11-20T13:39:53+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/daisy-macdermott/2025-11-20T13:43:07+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/dan-harding/2025-11-20T13:43:29+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/danielle-newport-fancher/2025-11-20T13:43:51+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/jaime-sanders/2025-11-20T13:51:47+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/jamie-saunders/2025-11-20T13:52:36+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/jeff-breece/2025-11-20T14:12:00+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/joanna-and-pawel/2025-11-20T14:15:00+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/john-bottrell/2025-11-20T14:15:44+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/jonathan-rottenberg/2025-11-20T14:16:08+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/jp-summers/2025-11-20T14:16:32+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/kamilah-howard/2025-11-20T14:22:11+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/kat-naish/2025-11-20T14:22:32+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/katie-m.-golden2025-11-20T14:23:19+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/kerri-mackay/2025-11-20T14:24:02+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/kimby-jagnandan/2025-11-20T14:24:21+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/laura-mckee/2025-11-20T14:24:40+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/lesley-mccuaig/2025-11-20T14:25:07+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/marc-lawrence/2025-11-20T14:33:40+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/martin-gallagher/2025-11-20T14:34:08+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/megan-potts/2025-11-20T14:34:42+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/michelle-rivas/2025-11-20T14:35:01+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/nachman-rosenberg/2025-11-20T14:35:31+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/natasha-lipman/2025-11-20T14:35:50+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/nerris-nassiri/2025-11-20T14:36:11+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/olivia-fulton/2025-11-20T14:36:41+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/rene-brooks/2025-11-20T14:37:20+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/rob-obey/2025-11-20T14:37:40+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/robert-joyce/2025-11-20T14:38:02+00:00yearly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/sarah-alexander/2025-11-20T14:40:08+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/sarah-bailey/2025-11-20T14:40:28+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/sarah-foster/2025-11-20T14:40:51+00:00weekly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/sarah-rathsack/2025-11-20T14:41:13+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/sukhy-bahia/2025-11-20T14:42:15+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/susanne-white/2025-11-20T14:42:41+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/teena-gates/2025-11-20T14:43:16+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/terry-matlen/2025-11-20T14:43:38+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/tim-wotton/2025-11-20T14:44:09+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/todd-seals/2025-11-20T14:44:33+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/trishna-bharadia/2025-11-20T14:45:06+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/willeke-van-eeckhoutte/2025-11-20T14:45:30+00:00monthly0.5https://www.tevapharm.com/our-company/corporate-governance/board-of-directors/2025-07-17T09:26:00+00:00yearly0.5https://www.tevapharm.com/product-focus/generics/medis--industry-leader-in-out-licensing/2024-11-20T14:10:16+00:00monthly0.5https://www.tevapharm.com/product-focus/generics/generics-faqs/2025-07-17T07:48:03+00:00monthly0.5https://www.tevapharm.com/product-focus/biopharmaceuticals/the-magic-of-biosimilars/2025-06-12T13:06:21+00:00monthly0.5https://www.tevapharm.com/product-focus/biopharmaceuticals/brief-history-of-biopharmaceuticals/2025-06-12T13:05:39+00:00monthly0.5https://www.tevapharm.com/science/iss-collaborative-research/registration-login/2025-10-30T13:19:50+00:00monthly0.5https://www.tevapharm.com/science/iss-collaborative-research/submission-process/2025-07-17T08:36:12+00:00monthly0.5https://www.tevapharm.com/science/iss-collaborative-research/about-iss-cr/2025-07-17T08:36:17+00:00weekly0.5https://www.tevapharm.com/our-company/corporate-governance/accessibility-statement/2025-07-17T09:27:06+00:00monthly0.5https://www.tevapharm.com/our-company/corporate-governance/global-PO-wording/2025-07-17T09:15:06+00:00monthly0.5https://www.tevapharm.com/our-company/corporate-governance/legal-notes/2025-07-17T09:14:11+00:00monthly0.5https://www.tevapharm.com/our-company/corporate-governance/raising-concerns/2025-07-17T09:13:07+00:00monthly0.5https://www.tevapharm.com/our-company/corporate-governance/prevention-of-corruption/2025-07-17T09:13:43+00:00monthly0.5https://www.tevapharm.com/our-company/corporate-governance/supplier-faqs/2025-07-17T09:10:56+00:00monthly0.5https://www.tevapharm.com/our-company/corporate-governance/committees-of-the-board/2025-07-17T09:18:33+00:00monthly0.5https://www.tevapharm.com/our-company/corporate-governance/teva-corporate-officers/2025-07-17T09:10:08+00:00yearly0.5https://www.tevapharm.com/our-company/corporate-governance/teva-privacy-notice/2025-07-17T09:05:20+00:00monthly0.5https://www.tevapharm.com/our-company/corporate-governance/data-privacy/2025-07-17T09:16:56+00:00monthly0.5https://www.tevapharm.com/our-company/corporate-governance/supplier-code-of-conduct/2025-07-17T09:12:12+00:00yearly0.5https://www.tevapharm.com/our-company/corporate-governance/corporate-governance-documents/2025-07-17T09:18:03+00:00yearly0.5https://www.tevapharm.com/news-and-media/feature-stories/hearing-loss-frank-mazzola/2025-07-17T10:21:56+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/diversity-fuels-innovation-teva-rd-team/2025-07-17T09:39:38+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/celebrating-pride-creating-connections/2025-07-17T08:48:56+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/mental-health-moments-breaking-barriers/2025-07-17T11:15:02+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/cory-wolhbach/2025-07-17T09:26:56+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/healthcare-trends-inclusion-diversity-irit-hovich/2025-05-23T10:14:02+00:00weekly0.5https://www.tevapharm.com/news-and-media/feature-stories/wellbeing-personal-stories-michele-hunter/2025-07-17T09:47:00+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/katarzyna-lozak/2025-07-17T10:58:34+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/susie-freda/2025-07-17T10:52:18+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/riad-dirani/2025-07-17T11:02:12+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/journey-into-patient-safety-book/2025-07-17T10:57:51+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/access-for-all/2025-07-17T07:47:53+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/how-teva-addresses-amr-global-threat-of-antimicrobial-resistance/2025-07-17T10:25:17+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/Advancing-access-to-essential-medicines/2025-10-28T11:23:43+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/an-artists-journey-into-patient-safety/2025-07-17T07:55:38+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/antibiotics-arent-always-the-solution/2025-07-17T07:56:56+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/pharmacists-connect-with-caregivers-in-canada/2025-07-17T11:08:31+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/art-of-patient-safety/2025-07-17T08:30:49+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/christoph-stoller-president-of-medicines-for-europe/2024-11-16T00:16:04+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/covid-19-medicine-supply-security/2025-10-28T16:06:36+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/into-the-eye-of-the-storm/2024-12-09T12:18:10+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/from-designing-televisions-and-telephones-to-innovating-with-autoinjectors/2025-07-17T09:46:48+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/from-educating-children-to-educating-our-customers-the-skills-that-help-everyday/2025-07-17T09:47:30+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/from-food-production-to-pharma-i-made-the-change-and-so-can-you/2025-07-17T09:48:48+00:00monthly0.5https://www.tevapharm.com/product-focus/generics/generics-medicine-development/2025-07-17T09:54:53+00:00monthly0.5https://www.tevapharm.com/product-focus/generics/generics-medicines-regulation/2025-07-17T09:55:40+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/helping-healthcare-services-resume-global/2025-10-28T16:07:09+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/hiv-awareness-look-facts/2024-12-09T09:56:18+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/get-dressed-for-work/2025-10-28T11:55:57+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/how-do-I-put-patient-safety-first/2024-11-16T00:16:21+00:00yearly0.5https://www.tevapharm.com/news-and-media/feature-stories/wellbeing-personal-stories-subhajit-goswami/2025-07-17T09:46:07+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/artificial-intelligence-advanced-analytics/2025-07-17T07:57:56+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/german-fleet-reducing-co2-emissions/2025-07-17T09:56:53+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/site-quality-head-development-program/2025-07-17T10:56:53+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/join-paul-hikky-and-amy-behind-the-scenes/2025-07-17T10:56:49+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/invisible-disability/2025-07-17T10:26:36+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/looking-ahead-greener-future/2025-07-17T10:59:15+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/making-connections-esg-report-2021/2025-06-10T13:23:48+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/meet-jozsef-szendi-teva-hungary-employee-for-49-years/2025-07-17T11:08:14+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/meet-kathy-konops/2025-07-17T11:08:49+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/meet-marcos-almendras/2025-07-17T11:09:54+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/masa-rajic-linaric/2025-07-17T11:03:09+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/mike-smith/2025-07-17T11:13:01+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/stefan-ottmar-fuegenschuh/2025-07-17T10:54:10+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/paula-turner/2025-07-17T11:09:05+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/meet-sarika-navara-teva-israel-employee-for-46-years/2025-07-17T11:12:04+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/beata-juhasz/2025-07-17T08:32:36+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/ivana-soljic-jerbic/2025-07-17T10:28:29+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/sebastian-horn/2025-07-17T10:57:47+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/samuel-frere-elena-lapkina-gendler/2025-07-17T10:59:09+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/meet-the-gatekeeper/2025-07-17T11:14:33+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/migraine-at-work-migraine-friendly-workplace-stamp/2025-07-17T11:13:51+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/mtsinai-new-mcc-research/2024-12-12T15:01:21+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/new-partnership-to-improve-mcc/2024-12-12T15:05:16+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/breast-cancer-ghana/2025-07-17T08:37:05+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/health-care-trends-ai-data-analytics/2025-07-17T10:07:08+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/healthcare-post-covid/2025-07-17T10:05:25+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/production-facility-bulgaria-india/2025-10-28T16:08:58+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/progress-and-more/2025-07-17T11:06:24+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/global-hope-teva-partnership/2025-07-17T10:01:40+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/the-ncd-care-continuum/2024-12-31T10:03:47+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/teva-erg-growing-with-pride/2025-07-17T10:36:19+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/teva-partnership-brings-critical-medicines-to-children-with-cancer/2025-07-17T10:05:51+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/academic-partnerships/2025-07-17T07:45:26+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/protecting-our-planet/2025-07-17T11:05:30+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/the-power-of-the-team-for-nurturing-mental-wellbeing/2025-07-17T09:52:25+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/rose-crane/2024-12-13T00:13:53+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/this-is-the-biggest-challenge-to-our-health/2025-07-17T09:51:20+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/uncovering-insights-on-multiple-chronic-conditions/2024-12-31T10:43:43+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/use-antibiotics-properly/2025-10-28T12:02:34+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/working-together-to-save-water/2025-07-17T09:32:16+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/wemake-arthur-lazarev-ufuk-aras/2025-07-17T09:41:34+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/wemake-crona-tansey-samantha-hendrick/2025-07-17T09:40:29+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/wemake-daniel-harding-asma-aktar/2025-07-17T09:39:30+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/WeMake-MST-Team/2025-07-17T09:37:07+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/Christina-Mazzella/2025-07-17T09:04:38+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/Irina-Stamenovska/2025-07-17T10:27:11+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/generics-medicine-people-global/2025-07-17T09:54:29+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/mental-health-advice-men/2025-07-17T11:15:53+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/clinical-trial-diversity/2025-07-17T09:18:38+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/working-hard-to-keep-medicines-moving/2025-07-17T09:31:37+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/questions-about-teva-environmental/2025-10-28T16:11:42+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/wemake-jamie-sanders-shachaf-reingewirtz/2025-07-17T10:35:12+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/getting-medicines-who-need/2025-07-17T09:57:45+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/clinical-trial-trends-eran-harary/2025-07-17T09:19:59+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/healthcare-trends-big-pharma-dana-baron/2025-07-17T10:08:58+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/teva-supplier-webinar-tevapharm/2025-07-17T09:56:51+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/healthcare-trends-sustainable-working-erick-tyssier/2025-07-17T10:15:09+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/sivan-ranon/2025-07-17T10:55:38+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/debrecen-hungary-rd-facility/2025-07-17T09:33:08+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/teva-2022-esg-progress-a-closer-look/2025-07-17T10:50:30+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/dr-eran-harary-haaretz-teva-innovation/2025-07-17T09:42:11+00:00weekly0.5https://www.tevapharm.com/news-and-media/feature-stories/teva-employees-talk-about-patient-safety/2025-07-17T10:37:16+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/meet-our-people-magdalena-zelazny/2025-07-17T11:10:32+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/healthcare-trends-finance-amit-hazan/2025-07-17T10:13:18+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/aion-labs-artificial-intelligence-ai/2025-07-17T07:52:16+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/how-does-teva-build-strong-career-pipelines/2025-07-17T10:24:32+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/beryl-ojwang-ai-patient-insights/2025-07-17T08:35:27+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/what-are-biologics-teva-discovery-sydney/2025-07-17T09:36:17+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/3-trends-im-watching-in-patient-safety/2025-07-17T07:42:21+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/meet-yuliana-katsarska/2025-07-17T11:15:08+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/a-loved-ones-perspective-on-living-with-tardive-dyskinesia/2025-07-17T07:52:56+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/mental-health-access-program-us/2025-07-17T11:15:50+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/helping-address-the-impact-of-tardive-dyskinesia/2025-07-17T10:22:40+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/stigma-around-schizophrenia-why-words-matter/2025-07-17T10:53:23+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/building-a-caregiver-team-when-living-with-schizophrenia/2025-07-17T08:38:22+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/meet-bikalpa-lalchan/2025-07-17T11:07:36+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/collaborating-to-innovate/2025-07-17T09:23:49+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/chris-fox-teva-us-commercial-interview/2025-07-17T08:49:40+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/eric-hughes-inspiring-women/2025-07-17T09:45:09+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/what-are-complex-generics/2025-07-17T09:33:52+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/going-green-for-greater-health/2025-07-17T10:02:58+00:00weekly0.5https://www.tevapharm.com/news-and-media/feature-stories/tgo-taps-into-diversity-drive-excellence/2025-07-17T09:55:58+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/celebrating-pride-across-the-world/2025-07-17T08:41:30+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/tevas-top-graduates-from-academic-learning-to-business-leadership/2025-07-17T09:57:51+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/tevas-top-graduates-developing-the-leaders-of-the-future/2025-07-17T09:58:57+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/manufacturing-supply-trends-dan-pritchett/2025-07-17T11:00:21+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/pivot-to-growth-teva-journey/2025-07-17T11:07:52+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/marathons-epic-swims-inspiring-stories-tevas-own-athletes/2025-10-30T13:09:16+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/healthcare-innovation-eric-hughes-ai/2025-10-28T11:57:54+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/track-trails-sporting-stories-tevas-own-champions/2025-07-17T09:50:01+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/what-are-biosimilars-biologics/2025-07-17T09:34:55+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/3-trends-im-watching-in-the-global-generics-industry/2025-07-17T07:43:54+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/teva-named-one-of-the-worlds-most-sustainable-companies/2025-07-28T13:05:24+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/sustainability-trends-amalia-adler-waxman/2025-07-17T10:51:27+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/teva-safety-physicians-medical-specialists-we-all-need/2025-07-17T09:59:58+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/jessica-payne-teva-jobs/2025-07-17T10:29:11+00:00monthly0.5https://www.tevapharm.com/news-and-media/feature-stories/the-neuroscience-of-inclusion-and-diversity-unlocking-high-impact-team-performance/2025-07-17T09:53:27+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/could-you-not-things-not-to-say-to-someone-with-adhd/2025-11-20T11:03:20+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/dont-call-me-maybe-ways-to-tackle-phone-anxiety/2025-11-20T12:37:37+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/unpacking-the-connection-between-ADHD-and-migraine/2025-11-20T11:07:36+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/are-you-okay/2025-11-20T10:36:58+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/conquer-fears-unknown-nature-anxiety/2025-11-20T11:03:47+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/nip-unwanted-cancer-advice/2025-11-20T11:04:04+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/disability-terms-i-hate/2025-11-20T11:06:48+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/adhd-time-management/2025-11-20T11:08:10+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/tips-to-combat-weight-gain-during-cancer-treatment/2025-11-20T11:21:31+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/movies-tv-shows-misrepresenting-depression/2025-11-20T11:21:56+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/challenges-tackled-with-asthma/2025-11-21T07:35:02+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/daily-habits-that-help-me-with-cystic-fibrosis/2025-11-21T07:36:54+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/ways-to-combat-airplane-anxiety/2025-11-21T07:37:33+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/powerful-self-care-habits-for-caregivers/2025-11-24T07:31:59+00:00weekly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/things-mindfulness-changed-about-living-with-asthma/2025-11-21T07:39:10+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/three-ways-procrastination-is-my-best-motivator/2025-11-21T07:40:14+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/ways-to-achieve-a-mental-reset-with-heart-failure/2025-11-21T07:40:48+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/everyday-behaviors-made-my-depression-worse/2025-11-21T07:42:30+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/myths-suicide/2025-11-21T07:43:22+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/people-who-inspire-to-live-with-asthma/2025-11-21T07:43:58+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/questions-about-future-with-adhd/2025-11-21T07:44:33+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/conquer-your-over-explaining-habit/2025-11-21T07:45:13+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/self-care-tips-for-caregivers/2025-11-21T07:46:50+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/combat-mental-health-stigma/2025-11-21T07:47:34+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/things-people-with-asthma-are-tired-of-hearing/2025-11-21T07:48:27+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/tips-to-avoid-control-issues-as-a-caregiver/2025-11-21T07:50:11+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/make-delegating-easier-for-caregivers/2025-11-21T07:50:56+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/tips-to-manage-relationships-after-a-Cancer-diagnosis/2025-11-21T08:02:42+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/ways-i-hide-depression/2025-11-21T07:52:43+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/ways-men-can-become-better-caregivers/2025-11-21T07:54:12+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/ways-to-ease-the-stress-of-family-caregiving/2025-11-21T07:54:49+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/help-a-loved-one-with-asthma/2025-11-21T07:57:53+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/winter-asthma-triggers/2025-11-21T08:04:07+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/affirmations-that-help-me-through-the-bad-days-with-depression/2025-11-21T10:42:59+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/five-conversation-challenges-with-adhd-and-tips-for-better-communication/2025-11-21T10:43:34+00:00weekly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/5-mindful-ways/2025-11-21T10:44:04+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/physical-symptoms-depression-anxiety/2025-11-21T10:44:34+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/when-people-dont-take-asthma-seriously/2025-11-21T10:45:29+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/surprising-things-that-make-my-migraine-attacks-worse/2025-11-21T10:46:04+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/terms-that-stigmatizes-mental-health/2025-11-21T10:46:44+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/things-depression-is-not/2025-11-21T10:47:23+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/tips-for-better-asthma-control/2025-11-21T10:48:03+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/five-tips-if-youre-considering-adult-adhd-counseling/2025-11-21T10:48:49+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/tips-to-communicate-adhd-to-your-partner/2025-11-21T10:49:25+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/get-the-most-from-your-doctor-as-a-caregiver/2025-11-21T10:51:11+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/tips-to-manage-adhd-at-work/2025-11-21T10:51:39+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/tips-when-youre-considering-therapy/2025-11-21T10:53:49+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/ways-caregivers-can-help-after-a-heart-attack/2025-11-21T10:56:26+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/growing-up-with-asthma-makes-me-a-great-asthma-parent/2025-11-21T10:57:06+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/give-heart-fighting-chance/2025-11-21T11:00:32+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/five-ways-to-better-understand-depression/2025-11-21T10:57:42+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/ways-to-find-hope-with-huntingtons-disease/2025-11-21T10:58:10+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/ways-to-find-the-truth-behind-depression/2025-11-21T10:59:06+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/expressions-people-with-migraine-are-tired-of-hearing/2025-11-21T11:03:31+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/things-i-couldve-told-my-teachers-about-my-adhd/2025-11-21T11:05:39+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/things-that-motivate-me-to-keep-fighting-migraine/2025-11-21T11:06:25+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/things-to-know-about-your-partner-with-heart-failure/2025-11-21T11:17:43+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/dating-with-social-anxiety/2025-11-21T11:07:18+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/tips-to-get-a-better-nights-sleep-with-copd/2025-11-21T11:07:56+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/managing-winter-depression/2025-11-21T11:08:29+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/tips-to-stick-to-your-new-diet-after-a-heart-attack/2025-11-21T11:12:23+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/ways-i-brought-positivity-back-into-my-life-after-a-heart-attack/2025-11-21T11:13:16+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/ways-to-cope-when-illness-confines-you-indoors/2025-11-21T11:14:00+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/ways-to-keep-caregiving-when-your-loved-one-gets-angry/2025-11-21T11:16:53+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/ways-to-help-cope-with-social-anxiety-this-christmas/2025-11-21T11:14:44+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/ways-to-thrive-in-self-isolating/2025-11-21T11:15:18+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/ways-to-use-your-adhd-curiosity-to-reach-your-goals/2025-11-21T11:15:52+00:00weekly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/exercise-tips-for-adhd/2025-11-21T12:02:47+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/caregiving-for-someone-with-a-chronic-condition/2025-11-21T12:04:42+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/home-hacks-for-asthma/2025-11-21T12:03:25+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/myths-about-depression/2025-11-21T12:05:22+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/copd-after-diagnosis/2025-11-21T12:06:06+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/self-advocacy-tips-for-chronic-migraine/2025-11-21T12:06:51+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/food-swaps-when-living-with-copd/2025-11-21T12:07:47+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/keep-your-asthma-symptoms-in-check-in-winter/2025-11-21T12:08:25+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/manage-adhd-in-workplace/2025-11-21T12:09:07+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/traveling-when-caregiving-for-a-loved-one/2025-11-21T12:09:52+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/tips-to-manage-migraine-food-cravings/2025-11-21T12:10:39+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/ways-i-cope-with-energy-drain-in-depression/2025-11-21T12:11:21+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/ways-educate-my-children-about-migraine-attacks/2025-11-21T12:11:53+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/ways-to-distinguish-between-depression-and-sadness/2025-11-21T12:12:19+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/handle-unwanted-advice-on-copd/2025-11-21T12:12:53+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/asthma-symptoms-you-shouldnt-ignore/2025-11-21T12:13:44+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/common-myths-about-copd-debunked/2025-11-21T12:14:53+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/life-lessons-migraine-taught-me/2025-11-21T12:15:25+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/migraine-warning-signs/2025-11-21T12:15:57+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/skills-to-manage-chronic-migraine/2025-11-21T12:16:33+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/manage-copd-exacerbations/2025-11-21T12:17:06+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/what-not-to-say-to-someone-with-depression/2025-11-21T12:17:37+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/tips-for-talking-about-asthma-with-others/2025-11-21T12:18:20+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/unusual-asthma-symptoms/2025-11-21T12:19:42+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/adhd-myths-before-diagnosed/2025-11-21T12:20:27+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/nine-questions-to-ask-yourself-about-your-depression/2025-11-21T12:20:56+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/questions-to-ask-if-living-with-depression/2025-11-21T12:21:22+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/self-care-tips/2025-11-21T12:21:51+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/day-in-my-life-with-asthma/2025-11-21T12:23:18+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/a-day-in-the-life-of-a-caregiver/2025-11-21T12:24:40+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/a-day-in-the-life-of-someone-with-adhd/2025-11-21T12:25:25+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/searching-for-my-hd-service-dog/2025-11-21T12:26:04+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/a-key-to-depression/2025-11-21T12:26:43+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/a-letter-to-myself-years-after-my-cancer-diagnosis/2025-11-21T12:27:53+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/lifetime-with-migraine/2025-11-21T12:28:28+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/real-week-with-chronic-migraine/2025-11-21T12:29:03+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/short-guide-to-travelling-with-heart-failure/2025-11-21T13:12:14+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/a-trip-to-the-psych-ward-reminded-me-how-much-my-family-valued-me/2025-11-21T13:12:57+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/accepting-my-fate-with-huntingtons-disease/2025-11-21T13:02:14+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/controlling-adhd-impulsivity/2025-11-21T13:11:28+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/adhd-and-long-term-relationships/2025-11-21T13:02:56+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/adhd-makes-me-messy-made-my-peace-with-it/2025-11-21T13:03:39+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/ask-for-help-with-asthma/2025-11-21T13:04:24+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/vision-problem-contributing-to-migraines/2025-11-21T13:10:37+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/animal-magnetism-why-our-brains-love-wildlife/2025-11-21T13:05:06+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/stand-up-comedy-as-a-full-time-caregiver/2025-11-21T13:07:50+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/asthma-and-anxiety-making-connections/2025-11-21T13:08:31+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/asthma-on-the-go-whats-in-your-bag/2025-11-21T13:09:05+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/asthma-allergies-and-me/2025-11-21T13:09:40+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/balancing-asthma-and-allergies/2025-11-24T07:16:22+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/what-new-caregivers-should-know/2025-11-24T07:21:12+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/behind-the-numbers-who-cares-for-the-carers/2025-11-24T07:21:45+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/cope-with-other-migraine-symptoms/2025-11-24T07:22:17+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/finding-my-asthma-family/2025-11-24T07:22:47+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/brain-rebellion-what-to-do-when-your-mind-works-against-you/2025-11-24T07:24:05+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/coping-strategies-for-depression/2025-11-24T07:23:13+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/can-dogs-help-with-stress-and-anxiety/2025-11-24T07:24:48+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/diet-affect-on-your-asthma/2025-11-24T07:25:51+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/can-you-learn-from-depression/2025-11-24T07:29:20+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/careers-and-adhd-find-the-right-fit/2025-11-24T07:29:54+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/words-of-wisdom-from-people-who-been-there/2025-11-24T07:30:22+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/caregiver-time-management/2025-11-24T07:30:56+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/accepting-negative-emotions-can-help-us/2025-11-24T07:31:27+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/caregiving-when-the-roles-are-reversed/2025-11-24T07:32:50+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/navigating-schizophrenia-as-a-partner-and-caregiver/2025-11-24T07:33:19+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/celebrating-small-victories-with-depression/2025-11-24T07:33:52+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/can-natural-disasters-put-people-with-asthma-at-risk/2025-11-24T07:36:17+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/changing-perceptions-my-top-adhd-advocates/2025-11-24T07:34:25+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/chronic-illness-in-the-instagram-era/2025-11-24T07:34:55+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/coping-with-isolation-in-migraine/2025-11-24T07:35:35+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/out-to-my-family-about-adhd/2025-11-20T11:02:06+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/coming-to-terms-with-chronic-illness-as-a-family/2025-11-24T07:37:07+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/your-adhd-diagnosis/2025-11-24T08:00:39+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/connecting-with-the-world-despite-depression/2025-11-24T08:01:27+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/coping-with-chronic-intractable-migraine/2025-11-24T08:02:21+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/coping-with-depression/2025-11-24T08:02:55+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/creating-a-gratitude-practice/2025-11-24T08:03:23+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/creating-an-effective-morning-routine-with-depression/2025-11-24T08:03:51+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/exercise-and-cystic-fibrosis/2025-11-24T08:04:17+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/anger-frustration-constant-pain/2025-11-24T08:09:03+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/dealing-with-anger-as-a-caregiver/2025-11-24T08:15:06+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/brain-fog-and-migraine/2025-11-24T08:15:47+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/pregnancy-scanxiety-after-cancer/2025-11-24T08:16:27+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/debunking-dangerous-asthma-myths/2025-11-24T08:17:30+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/depression-and-the-highly-sensitive-person/2025-11-24T08:18:09+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/depression-in-the-age-of-conspicuous-positivity/2025-11-24T08:18:51+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/changing-how-we-see-depression/2025-11-24T08:20:06+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/depression-vs-burnout/2025-11-24T08:21:10+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/depression-and-ADHD/2025-11-24T08:21:45+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/manage-adhd/2025-11-24T08:22:17+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/diagnosed-with-asthma/2025-11-24T08:22:52+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/distraction-techniques-migraine-pain/2025-11-24T08:23:32+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/divorced-and-dating-again-with-adhd/2025-11-24T08:24:00+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/do-less-achieve-more/2025-11-24T08:24:37+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/driving-with-migraine-dangers/2025-11-24T08:25:15+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/essential-caregiver-communication-skills/2025-11-24T08:33:10+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/exercise-with-asthma-yes-you-can/2025-11-24T08:34:30+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/huntingtons-disease-psychosis-experience/2025-11-24T08:35:07+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/post-traumatic-growth-cystic-fibrosis/2025-11-24T08:35:45+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/facing-anger-and-uncertainty-as-a-young-caregiver/2025-11-24T08:37:07+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/facing-unexpected-fertility-decisions-after-my-cancer-diagnosis/2025-11-24T08:36:22+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/ways-asthma-affects-my-life/2025-11-24T08:38:16+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/finding-and-building-community-around-you/2025-11-24T08:38:49+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/finding-empowerment-through-migraine-advocacy/2025-11-24T08:39:39+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/migraine-support-through-technology/2025-11-24T08:40:10+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/migraine-conversation-through-the-ages/2025-11-24T08:40:41+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/poems-about-living-with-migraine/2025-11-24T08:41:13+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/dating-with-schizophrenia/2025-11-24T08:43:23+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/cold-and-flu-season-with-asthma/2025-11-24T08:45:54+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/plan-migraine-friendly-vacation/2025-11-24T08:43:57+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/creating-a-gratitude-isnt-easy/2025-11-24T08:44:28+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/growing-up-with-asthma-and-bullies/2025-11-24T08:45:00+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/life-with-service-dog/2025-11-24T08:47:48+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/hope-or-hype-could-houseplants-help-asthma/2025-11-24T07:25:23+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/say-yes-to-inner-child/2025-11-24T08:48:49+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/daily-routine-helps-migraines/2025-11-24T09:04:24+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/how-parents-manage-their-depression/2025-11-24T08:49:26+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/late-adhd-changed-my-life/2025-11-24T08:50:45+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/how-a-scary-movie-helped-me-manage-my-anxiety/2025-11-24T08:51:59+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/adhd-different-in-adults-and-kids/2025-11-24T08:53:31+00:00weekly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/adhd-queen-of-distraction/2025-11-24T08:54:04+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/how-asserting-boundaries-can-help-with-anxiety/2025-11-24T08:55:12+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/asthma-onto-career-path-i-love/2025-11-24T08:56:01+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/how-cancer-changed-me-as-a-person/2025-11-24T08:56:39+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/caregiving-and-friendships-a-lonely-love/2025-11-24T08:57:18+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/chronic-pain-led-to-self-discovery/2025-11-24T08:58:00+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/type-two-diabetes-and-heart-failure/2025-11-24T08:58:39+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/how-hd-affects-my-communication-skills/2025-11-24T09:00:01+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/how-i-break-the-cycle-of-depression-and-isolation/2025-11-24T09:00:37+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/how-i-deal-with-migraine-anxiety/2025-11-24T09:01:17+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/how-i-finally-chose-my-college-major-with-adhd/2025-11-24T09:01:54+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/how-i-fought-to-get-my-asthma-diagnosis/2025-11-24T09:02:32+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/keep-moving-despite-migraine/2025-11-24T09:03:03+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/stop-apologizing-for-adhd/2025-11-24T09:03:40+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/managing-fear-of-flares-with-chronic-illness/2025-11-24T09:11:02+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/reading-books-despite-adhd/2025-11-24T09:10:29+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/how-i-realized-i-was-depressed/2025-11-24T09:09:52+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/how-i-rekindled-intimacy-despite-prostate-cancer/2025-11-24T09:09:20+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/stop-migraine-get-in-way-of-carrer/2025-11-24T09:08:47+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/taking-care-of-mind-and-body-with-asthma/2025-11-24T09:08:12+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/how-i-talk-about-migraine-at-work/2025-11-24T09:07:32+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/self-care-with-ms/2025-11-24T09:06:57+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/losing-weight-improved-asthma-symptoms/2025-11-24T09:05:38+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/finding-resilience-with-cystic-fibrosis-related-diabetes/2025-11-24T09:35:34+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/migraine-marriage-career-impact/2025-11-24T09:36:14+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/how-migraine-affects-my-appetite/2025-11-24T09:37:44+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/migraine-impact-on-work-and-relationships/2025-11-24T09:38:13+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/migraine-changing-friendships-social-life/2025-11-24T09:39:34+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/how-my-children-feel-about-family-life-with-a-chronically-ill-parent/2025-11-24T09:40:04+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/mental-health-affects-parenting-style/2025-11-24T09:40:31+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/how-pets-can-help-fight-depression/2025-11-24T09:41:05+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/how-pets-can-help-improve-your-life/2025-11-24T09:41:30+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/how-quitting-social-media-has-helped-my-mental-health/2025-11-24T09:42:00+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/the-next-generation-of-family-caregivers/2025-11-24T09:43:26+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/how-storytelling-helped-me-through-my-cancer-diagnosis/2025-11-24T09:43:47+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/escaping-caregiver-burnout/2025-11-24T09:44:19+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/coping-with-survivors-guilt-and-cancer/2025-11-24T09:45:04+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/how-to-create-a-migraine-binder-for-er-visits-and-doctors-appointments/2025-11-24T09:45:34+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/dealing-with-fomo-in-chronic-illness/2025-11-24T09:46:09+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/how-to-deal-with-being-guilt-tripped-over-your-mental-health/2025-11-24T09:47:09+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/discussing-uncomfortable-topics-as-caregivers/2025-11-24T09:47:38+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/explaining-your-migraine-to-teenage-children/2025-11-24T09:48:08+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/fight-disconnection-when-depressed/2025-11-24T09:48:34+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/how-to-help-a-loved-one-when-depression-becomes-a-crisis/2025-11-24T09:49:37+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/how-to-let-go-of-perfectionism-as-a-caregiver/2025-11-24T09:50:14+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/manage-photophobia-and-migraine/2025-11-24T09:50:57+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/how-to-navigate-toxic-relationships-with-depression/2025-11-24T09:51:27+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/overcoming-imposter-syndrome-as-a-family-caregiver/2025-11-24T09:51:50+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/run-a-race-with-asthma/2025-11-24T09:52:28+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/practical-support-migraine-attacks/2025-11-24T09:54:36+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/talk-to-children-about-asthma/2025-11-24T09:55:03+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/talking-to-your-partner-about-migraine/2025-11-24T09:55:25+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/weather-changes-affect-my-migraine/2025-11-24T09:55:59+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/weight-lifting-inner-strength-post-cancer/2025-11-24T09:56:25+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/adhd-hyperfocus-a-double-edged-sword/2025-11-24T09:56:49+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/tips-for-managing-projects-with-adhd/2025-11-24T09:57:40+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/i-changed-my-mind-about-psychotherapy-after-surviving-a-heart-attack/2025-11-24T10:01:29+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/i-have-my-asthma-to-thank-for-making-me-smarter/2025-11-24T09:58:13+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/plan-wedding-with-adhd/2025-11-24T09:58:41+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/opening-up-about-copd-at-work/2025-11-24T09:59:14+00:00weekly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/mom-with-migraine/2025-11-24T10:00:18+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/illustrating-the-a-to-z-of-mental-health/2025-11-24T10:00:46+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/imposter-syndrome-with-chronic-illness/2025-11-24T10:02:03+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/my-future-with-hd/2025-11-24T10:17:41+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/seasonal-allergies-or-migraine-know-the-difference/2025-11-24T10:18:07+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/is-it-time-to-see-more-of-the-real-you/2025-11-24T10:18:30+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/is-lack-of-sleep-seriously-affecting-your-mood/2025-11-24T10:18:55+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/is-this-a-heart-attack-when-panic-attacks-hit-hard/2025-11-24T10:19:17+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/ive-had-a-migraine/2025-11-24T09:59:42+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/setting-boundaries-living-with-migraine/2025-11-24T10:19:47+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/lets-talk-about-asthma/2025-11-24T10:20:14+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/lets-talk-about-multiple-sclerosis-ms/2025-11-24T10:20:38+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/lets-talk-about-migraine/2025-11-24T10:21:03+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/asthma-myths-vs-personal-experience/2025-11-24T10:21:31+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/living-life-to-the-fullest-with-huntingtons-disease/2025-11-24T10:22:01+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/living-with-chronic-migraine-phrases-to-remove-from-dialogue/2025-11-24T10:22:22+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/experiencing-delusions-and-dissociation-in-childhood/2025-11-24T10:22:49+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/living-with-migraine-work-home-social/2025-11-24T10:23:12+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/escape-toxic-cycle-perfectionism/2025-11-24T10:24:01+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/losing-each-other-when-caregiving-as-a-family/2025-11-24T10:24:29+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/losing-my-migraine-companion/2025-11-24T10:24:55+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/dating-with-migraine/2025-11-24T10:25:21+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/ADHD-low-self-esteem/2025-11-24T10:25:53+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/making-it-through-a-crisis-one-day-at-a-time/2025-11-24T10:31:34+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/making-your-adhd-work-in-the-office/2025-11-24T10:28:08+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/managing-a-household-and-migraine/2025-11-24T10:26:34+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/managing-asthma-on-my-wedding-day/2025-11-24T10:25:42+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/managing-childbirth-trauma-breastfeeding-guilt/2025-11-24T10:24:48+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/managing-family-vacations-with-migraine/2025-11-24T10:23:52+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/low-energy-chronic-migraine/2025-11-24T10:22:14+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/mixed-emotions-cancer-awareness-months/2025-11-24T10:18:48+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/managing-your-asthma-as-a-new-mom/2025-11-24T10:15:51+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/meal-planning-with-adhd/2025-11-24T10:14:43+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/migraine-brain-fog/2025-11-24T10:13:43+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/migraine-and-weight-gain-are-they-linked/2025-11-24T10:05:25+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/migraine-moments-laughing-through-pain/2025-11-24T10:04:33+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/migraines-at-work-how-to-push-through-the-pain-and-when-to-call-it-quits/2025-11-24T10:02:38+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/mindfulness-and-adhd/2025-11-24T10:01:49+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/ms-having-children-choices/2025-11-24T10:00:43+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/motherhood-and-migraine-how-cope-with-mom-guilt/2025-11-24T09:59:56+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/moving-in-with-a-partner-when-you-have-asthma/2025-11-24T09:49:06+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/moving-to-a-new-home-the-asthma-friendly-way/2025-11-24T09:57:28+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/my-depression-playlist-turning-to-music-during-depression/2025-11-24T09:55:16+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/my-favorite-apps-and-tools-for-adhd/2025-11-24T09:54:25+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/first-marathon-with-asthma/2025-11-24T09:53:26+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/first-migraine-and-what-ive-learned/2025-11-24T09:52:21+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/heart-healthy-lifestyle-changes/2025-11-24T09:51:17+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/my-husband-my-caregiver-our-days-living-with-hd/2025-11-24T09:50:16+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/my-life-with-migraine/2025-11-24T09:48:57+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/my-meditation-tips-for-people-with-adhd/2025-11-24T09:47:43+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/my-migraine-story/2025-11-24T09:46:36+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/migraine-friendly-food-swaps/2025-11-24T09:45:21+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/me-my-mom-and-migraine/2025-11-24T09:44:24+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/can-migraine-trigger-vertigo-dizziness/2025-11-24T09:43:29+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/springtime-asthma-arsenal/2025-11-24T09:42:32+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/my-sudden-stroke-was-actually-hemiplegic-migraine/2025-11-24T09:40:24+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/adhd-morning-routine/2025-11-24T09:38:43+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/my-worst-adhd-triggers/2025-11-24T09:37:34+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/navigating-digital-worlds-with-depression-and-anxiety/2025-11-24T09:36:03+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/navigating-relationships-after-psychosis/2025-11-24T09:34:05+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/navigating-the-challenges-and-joys-of-caregiving/2025-11-24T09:32:40+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/navigating-the-er-with-migraine/2025-11-24T09:31:49+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/living-with-huntingtons/2025-11-24T09:29:32+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/opening-up-about-asthma-and-intimacy/2025-11-24T09:28:32+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/parenting-guilt-with-chronic-migraine/2025-11-24T09:27:35+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/parenting-with-depression-and-anxiety/2025-11-24T09:26:27+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/tight-hairstyle-migraine-trigger/2025-11-24T09:24:56+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/career-progression-with-chronic-migraine/2025-11-24T09:23:20+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/prostate-cancer-changed-my-life-for-better/2025-11-24T09:21:58+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/reclaiming-your-identity-outside-of-depression/2025-11-24T09:21:06+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/reducing-hazards-as-hd-progresses/2025-11-24T09:19:43+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/returning-to-therapy-my-hardest-mental-health-journey-yet/2025-11-24T09:18:35+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/returning-to-work-after-cancer/2025-11-24T09:16:37+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/managing-chronic-pain-with-exercise/2025-11-24T09:14:22+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/safely-exercising-with-asthma-during-pregnancy/2025-11-24T09:12:48+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/schizophrenia-and-marriage-resilience-and-understanding/2025-11-24T09:04:54+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/self-kindness-and-anxiety-fake-it-til-you-make-it/2025-11-24T09:03:36+00:00weekly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/should-you-keep-an-asthma-diary/2025-11-24T09:01:17+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/knowing-when-heart-needs-tlc/2025-11-24T08:59:44+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/finding-peace-with-hd/2025-11-24T08:58:27+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/staying-calm-caregiving-in-the-face-of-anger/2025-11-24T08:56:27+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/strange-ways-i-feel-depression/2025-11-24T08:53:19+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/hemiplegic-migraine-stress-lifestyle/2025-11-24T08:51:57+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/study-hacks-that-worked-for-my-adhd/2025-11-24T08:49:18+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/supporting-someone-with-depression/2025-11-24T08:47:29+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/surviving-a-heart-attack/2025-11-24T08:45:59+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/surviving-the-holidays-with-chronic-migraine/2025-11-24T08:44:16+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/surviving-university-with-asthma/2025-11-24T08:42:19+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/talking-to-kids-about-asthma/2025-11-24T08:40:59+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/talking-to-kids-about-migraine/2025-11-24T08:40:12+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/chronic-illness-and-unsolicited-advice/2025-11-24T08:32:46+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/the-steps-i-took-to-love-myself-with-depression/2025-11-24T08:31:32+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/the-anatomy-of-a-migraine/2025-11-24T08:29:58+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/adhd-procrastination-black-hole/2025-11-24T08:24:55+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/the-caregivers-stress-triad-fear-fatigue-and-failure/2025-11-24T08:07:31+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/the-day-i-rediscovered-patience-as-a-caregiver/2025-11-24T08:05:41+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/things-people-told-me-about-my-adhd/2025-11-24T08:03:35+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/the-emotional-toll-of-asthma/2025-11-24T07:59:42+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/the-hidden-impact-of-migraine-on-millions-of-women/2025-11-24T07:57:30+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/language-about-invisible-illness/2025-11-24T07:56:20+00:00weekly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/doctor-breathlessness/2025-11-24T07:54:33+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/mental-health-advocate/2025-11-24T07:52:36+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/the-problem-with-not-talking-about-heart-failure/2025-11-24T07:49:56+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/the-recharging-power-of-routines-to-manage-depression-and-anxiety/2025-11-24T07:48:38+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/a-dad-with-cystic-fibrosis/2025-11-21T14:40:15+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/the-silent-epidemic-of-mens-mental-health/2025-11-21T14:26:27+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/the-one-big-thing-people-get-wrong-about-heart-disease/2025-11-21T14:25:21+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/things-i-love-about-my-adhd/2025-11-21T14:24:09+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/things-that-happened-when-i-started-talking-about-my-depression/2025-11-21T13:51:50+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/this-is-my-depression-support-team/2025-11-21T13:50:47+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/migraine-care-team/2025-11-21T13:49:17+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/this-is-what-a-bad-day-with-adhd-looks-like/2025-11-21T13:48:22+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/this-is-what-asthma-actually-feels-like/2025-11-21T13:46:55+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/times-ive-hidden-my-migraine-from-others/2025-11-21T13:45:41+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/adapting-to-change-as-caregivers/2025-11-21T13:44:33+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/tips-for-a-better-nights-sleep-with-asthma/2025-11-21T13:43:30+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/how-to-pay-attention-school-work-home/2025-11-21T13:42:29+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/toughing-it-out-with-migraine/2025-11-21T13:41:19+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/traveling-with-migraine/2025-11-21T13:40:13+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/traveling-with-schizophrenia-my-key-considerations/2025-11-21T13:39:10+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/visual-metaphors-for-depression-conversation/2025-11-21T13:37:55+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/visualizing-your-best-self-outside-depression/2025-11-21T13:36:39+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/what-a-mental-health-re-diagnosis-means-to-me/2025-11-21T13:34:51+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/what-adhd-feels-like/2025-11-21T12:34:23+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/barriers-to-adult-adhd-diagnosis/2025-11-21T12:32:56+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/what-caregiving-taught-me-about-holiday-magic/2025-11-21T12:31:37+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/what-i-need-to-hear-as-a-mum-with-anxiety/2025-11-21T12:23:23+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/socially-acceptable-responses-hide-real-feelings/2025-11-21T12:17:31+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/loved-ones-to-understand-about-migraine/2025-11-21T12:16:14+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/know-before-migraine-becomes-my-chronic-disease/2025-11-21T12:15:05+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/what-i-wish-my-parents-knew-about-my-mental-health-struggles/2025-11-21T12:13:42+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/what-its-like-to-experience-the-holidays-with-depression/2025-11-21T12:09:08+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/what-to-do-if-your-colleagues-dont-believe-you-get-migraine-attacks/2025-11-21T12:07:23+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/asthma-relationship-buzzkill/2025-11-21T12:03:04+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/what-to-do-when-your-tools-arent-working/2025-11-21T12:00:43+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/struggling-with-depression/2025-11-21T11:53:30+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/tips-to-ease-the-transition-of-changing-jobs/2025-11-21T11:51:58+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/when-migraine-runs-in-the-family/2025-11-21T11:50:28+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/when-someone-you-love-forgets-your-name/2025-11-21T11:48:59+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/caregiver-with-chronic-illness/2025-11-21T11:47:08+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/create-your-migraine-elevator-pitch/2025-11-21T11:44:34+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/asthma-is-more-linked-emotion/2025-11-21T11:43:00+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/changed-my-mind-about-online-therapy/2025-11-21T11:41:22+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/starting-my-business-with-ADHD/2025-11-21T11:39:33+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/why-i-decided-to-run-a-marathon-with-stage-four-cancer/2025-11-21T11:37:43+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/why-i-froze-my-embryos-after-my-cancer-diagnosis/2025-11-21T11:36:25+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/why-i-wont-hide-my-asthma/2025-11-21T11:25:14+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/why-migraine-made-me-ditch-my-to-do-list/2025-11-21T10:37:37+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/why-safe-spaces-are-so-important-for-people-of-color/2025-11-21T10:35:43+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/why-self-care-is-so-important-when-you-have-adhd/2025-11-21T10:34:17+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/why-we-need-to-destigmatize-migraine/2025-11-21T10:33:25+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/stop-social-media-scare-tactics/2025-11-21T10:25:52+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/hungover-after-a-migraine-attack/2025-11-21T10:23:13+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/why-you-need-to-be-kind-to-yourself-after-an-asthma-flare-up/2025-11-21T10:24:33+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/will-my-kids-have-asthma/2025-11-21T09:32:53+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/winning-at-the-workplace-despite-cystic-fibrosis/2025-11-21T09:05:48+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/work-life-balance-tips-when-you-have-adhd/2025-11-21T09:02:15+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/working-with-chronic-migraine/2025-11-21T09:00:41+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-statement-on-donation-of-covid-19-related-treatments/2025-06-06T13:39:27+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-drives-positive-impact-in-response-to-covid-19-pandemic/2025-06-06T13:29:35+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-pharmaceuticals-and-volunteers-in-medicine-partner-to-expand-access-to-healthcare-in-the-u.s2024-11-16T00:19:50+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-generic-xeloda-tablets-150-mg-and-500-mg-in-the-united-states/2024-11-16T00:19:52+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-hosts-uk-and-israeli-prime-ministers-at-uk-israel-innovation-event--announce-collaboration-on-new-n/2024-11-16T00:19:53+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-approval-of-generic-evista-tablets-60-mg-in-the-united-states/2024-11-16T00:19:54+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-launches-adasuve-in-u.s2024-11-16T00:19:55+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-cowen--company-34th-annual-healthcare-conference/2024-11-16T00:19:56+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-files-2013-annual-report-on-form20-f/2024-11-16T00:19:56+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-citi-2014-global-healthcare-conference/2024-11-16T00:19:58+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-completes-tender-offer-for-nupathe-inc.-shares2024-11-16T00:19:58+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-full-fda-approval-of-synribo-omacetaxine-mepesuccinate-for-injection/2024-11-16T00:19:59+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-fourth-quarter-and-full-year-2013-results/2024-11-16T00:20:00+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-u.s.-fda-approval-of-three-times-a-week-copaxone-glatiramer-acetate-injection-40mgml2024-11-16T00:20:01+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-active-biotech-remain-committed-to-the-development-of-nerventra-laquinimod-for-multiple-scler/2024-11-16T00:20:02+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-expands-cns-specialty-business-with-acquisition-of-nupathe/2024-11-16T00:20:03+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/data-demonstrates-key-genes-respond-differently-to-copaxone-glatiramer-acetate-injection-versus-a-purp/2024-11-16T00:20:03+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-32nd-annual-j.p.-morgan-healthcare-conference2024-11-16T00:20:04+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-names-erez-vigodman-as-president-and-ceo/2024-11-16T00:20:05+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-third-quarter-2014-results/2024-11-16T00:20:07+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-initiation-of-new-drug-application-and-positive-results-from-second-human-abuse-liability-/2024-11-16T00:20:08+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-report-third-quarter-2014-financial-results-on-october-30-2014/2024-11-16T00:20:08+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-results-of-strategic-review-of-core-specialty-therapeutic-areas/2024-11-16T00:20:09+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-presents-gene-expression-analysis-at-joint-actrims-ectrims-meeting-demonstrating-copaxone-glatiram/2024-11-16T00:20:10+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-presents-new-clinical-safety-data-in-rrms-patients-treated-with-laquinimod-for-two-or-more-years-at-/2024-11-16T00:20:11+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-presents-new-data-which-demonstrate-reduction-of-injection-related-adverse-events-with-the-less-freq/2024-11-16T00:20:12+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/successful-completion-of-phase-iii-program-for-tevas-reslizumab-two-more-phase-iii-studies-support-the-b/2024-11-16T00:20:13+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-generic-baraclude-tablets-0.5mg-and-1mg-in-the-united-states2024-11-16T00:20:14+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-morgan-stanley-global-healthcare-conference/2024-11-16T00:20:14+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-launches-syncaretm-home-administration-support-program-for-patients-on-synribo-omacetaxine-mepesuc/2024-11-16T00:20:16+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/data-to-be-presented-at-ms-boston-2014-joint-actrims-ectrims-meeting-underscore-tevas-commitment-to-dev/2024-11-16T00:20:16+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-uk-high-court-gives-positive-judgment-in-the-companys-patent-case-against-astrazeneca/2024-11-16T00:20:17+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/tevas-reslizumab-delivers-clinically-and-statistically-significant-reduction-in-asthma-exacerbations-in-/2024-11-16T00:20:18+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-comments-on-receipt-of-first-paragraph-iv-notice-for-copaxone-40-mgml-glatiramer-acetate-injectio/2024-11-16T00:20:19+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-second-quarter-2014-results/2024-11-16T00:20:19+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/all-proposals-approved-at-tevas-annual-meeting-of-shareholders/2024-11-16T00:20:20+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-completes-acquisition-of-labrys-opens-door-to-a-strong-and-novel-migraine-prevention-and-treatment-/2024-11-16T00:20:21+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-report-second-quarter-2014-financial-results-on-july-31-2014/2024-11-16T00:20:22+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/collaboration-agreement-innovative-cancer-brain-studies/2024-11-16T00:20:23+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-the-weizmann-institute/2024-11-16T00:20:25+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/leading-u.s.-proxy-advisory-firm-supports-teva-nominees-and-other-shareholders-meeting-proposals2024-11-16T00:20:26+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-fda-acceptance-of-nda-filing-for-investigational-short-acting-beta-agonist-saba-inhaler-/2024-11-16T00:20:27+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/adding-multimedia-teva-files-citizen-petition-with-the-u.s.-food-and-drug-administration-fda-regarding-2024-11-16T00:20:28+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reaches-settlement-in-proair-hfa-patent-case/2024-11-16T00:20:29+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reaches-settlements-in-nuvigil-patent-case/2024-11-16T00:20:30+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-u.s.-court-of-appeals-upholds-ruling-confirming-invalidity-of-baraclude-patent2024-11-16T00:20:31+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/fda-approves-expanded-label-for-azilect-for-treatment-across-all-stages-of-parkinsons-disease/2024-11-16T00:20:32+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-goldman-sachs-35th-annual-global-healthcare-conference/2024-11-16T00:20:33+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-acquire-labrys-biologics-inc.-novel-migraine-prophylaxis-treatment-adds-significant-new-dimensi2024-11-16T00:20:34+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-new-organizational-structure-and-senior-leadership-changes-enabling-the-global-integratio/2024-11-16T00:20:35+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-receives-favorable-court-decision-regarding-generic-celebrex-capsules-teva-should-receive-sole-exc/2024-11-16T00:20:36+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-jefferies-2014-global-healthcare-conference/2024-11-16T00:20:37+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-received-fda-approval-for-qvar-beclomethasone-dipropionate-hfa-with-dose-counter/2024-11-16T00:20:38+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-active-biotech-to-continue-with-the-development-of-nerventra-laquinimod-for-multiple-sclerosi/2024-11-16T00:20:39+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-ubs-global-healthcare-conference/2024-11-16T00:20:40+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-fda-acceptance-of-snda-filing-for-pediatric-indication-for-qnasl-beclomethasone-dipropio/2024-11-16T00:20:41+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-bank-of-america-merrill-lynch-2014-health-care-conference/2024-11-16T00:20:41+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-copaxone-recognized-as-brand-of-the-year-by-pharmaceutical-executive-magazine/2024-11-16T00:20:42+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/fda-approves-tevas-synribo-omacetaxine-mepesuccinate-for-injection-for-home-administration/2024-11-16T00:20:43+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-first-quarter-2014-results/2024-11-16T00:20:44+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-shares-new-data-on-ms-therapies-at-66th-american-academy-of-neurology-aan-annual-meeting/2024-11-16T00:20:45+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-issues-updated-conference-call-information-for-first-quarter-2014-financial-results-on-may-1-2014/2024-11-16T00:20:46+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-positive-results-from-pivotal-phase-iii-study-to-evaluate-hydrocodone-bitartrate-extended-re/2024-11-16T00:20:46+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-oncogenex-announce-top-line-survival-results-of-phase-iii-synergy-trial-evaluating-custirsen-in-/2024-11-16T00:20:47+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/pride-hd-study-enrolling-patients-globally-to-further-evaluate-pridopidine-for-the-symptomatic-treatment-/2024-11-16T00:20:48+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-supreme-court-denial-of-request-for-interim-relief-to-stay-court-of-appeals-ruling-for-cop/2024-11-16T00:20:49+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-settles-patent-litigation-with-pfizer-on-celebrex/2024-11-16T00:20:50+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-generic-lunesta-tablets-in-the-united-states/2024-11-16T00:20:50+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-first-approval-and-launch-of-generic-lovaza-capsules-in-the-united-states/2024-11-16T00:20:51+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-u.s.-supreme-court-will-hear-its-appeal-on-copaxone-patent2024-11-16T00:20:52+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-report-first-quarter-2014-financial-results-on-may-1-2014/2024-11-16T00:20:53+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-launches-generic-abilify-tablets-in-the-united-states/2024-11-16T00:20:54+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-continues-to-invigorate-injectable-portfolio-with-the-launch-of-argatroban-injection-in-the-united-s/2024-11-16T00:20:54+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reiterates-commitment-to-cash-and-stock-acquisition-of-mylan-for-$82.00-per-share2024-11-16T00:20:55+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-active-biotech-announce-first-patient-enrolled-in-phase-ii-study-evaluating-laquinimod-for-prima/2024-11-16T00:20:56+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-presents-data-comparing-early-treatment-with-copaxone-40-mgml-to-delayed-start-treatment-at-67th-a/2024-11-16T00:20:57+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-files-for-hart-scott-rodino-notification-regarding-proposed-acquisition-of-mylan/2024-11-16T00:20:59+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-proposes-to-acquire-mylan-for-$82.00-per-share-in-cash-and-stock2024-11-16T00:20:59+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-report-first-quarter-2015-financial-results-on-april-30-2015/2024-11-16T00:21:01+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-eagle-pharmaceuticals-announce-nda-for-bendamustine-rapid-infusion-product-accepted-for-filing/2024-11-16T00:21:02+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/Global-Partnership-Cancer-Medicines-to-Children-in-Africa/2025-10-28T16:14:23+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-multiple-sclerosis-data-at-67th-american-academy-of-neurology-aan-annual-meeting-in-was/2024-11-16T00:21:03+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-xenon-announce-enrollment-of-first-patient-in-a-phase-2b-study-evaluating-tv-45070-for-postherpe/2024-11-16T00:21:04+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-fda-approval-of-proair-respiclick/2024-11-16T00:21:05+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-expands-hypertension-line-with-launch-of-generic-exforge-tablets-in-the-united-states/2024-11-16T00:21:07+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reinforces-leadership-position-in-cns-with-acquisition-of-auspex/2024-11-16T00:21:08+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-pricing-of-2-billion-of-senior-notes/2024-11-16T00:21:09+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-new-head-of-business-development-strategy-and-innovation/2024-11-16T00:21:10+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/tevas-tev-48125-meets-primary-and-secondary-endpoints-in-episodic-migraine-study-demonstrating-treatmen/2024-11-16T00:21:11+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-ignyta-announce-acquisition-by-ignyta-of-four-oncology-rd-assets-from-teva/2024-11-16T00:21:12+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-barclays-global-healthcare-conference/2024-11-16T00:21:13+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-sale-of-sellersville-pa-facility/2024-11-16T00:21:14+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-early-results-of-debt-tender-offer-pricing-election-of-early-settlement-and-increase-in-/2024-11-16T00:21:15+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-cowen--company-35th-annual-healthcare-conference/2024-11-16T00:21:16+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-fda-acceptance-for-review-of-nda-for-its-investigational-twice-daily-hydrocodone-bitartrat/2024-11-16T00:21:17+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-positive-results-for-tev-48125-in-phase-iib-chronic-migraine-study-meeting-primary-and-sec/2024-11-16T00:21:18+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/the-lancet-respiratory-medicine-and-aaaai-publish-positive-data-from-phase-iii-trials-of-tevas-reslizuma/2024-11-16T00:21:19+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-new-respiratory-data-at-2015-annual-meeting-of-the-american-academy-of-allergy-asthma-an/2024-11-16T00:21:20+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-bolsters-injectable-portfolio-with-launch-of-generic-lovenox-and-generic-zyvox-in-the-united-state/2024-11-16T00:21:21+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-eagle-pharmaceuticals-announce-tevas-license-to-commercialize-eagles-bendamustine-rapid-infusi/2024-11-16T00:21:22+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-$1-billion-debt-tender-offer/2024-11-16T00:21:23+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-files-2014-annual-report-on-form20-f/2024-11-16T00:21:23+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-fourth-quarter-and-full-year-2014-results/2024-11-16T00:21:24+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-thanks-dr.-phillip-frost-for-board-service2024-11-16T00:21:25+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-receives-fda-approval-for-first-generic-nexiumdelayed-release-capsulesin-the-united-states/2024-11-16T00:21:26+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-u.s.-supreme-court-decision-to-reverse-federal-circuit-courts-judgment-on-copaxone-20-mg2024-11-16T00:21:27+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-report-fourth-quarter-2014-financial-results-on-february-5-2015/2024-11-16T00:21:28+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-33rd-annual-j.p.-morgan-healthcare-conference2024-11-16T00:21:29+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-launches-generic-diovan-in-the-united-states/2024-11-16T00:21:30+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-goldman-sachs-healthcare-ceos-unscripted-conference/2024-11-16T00:21:31+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/fda-approves-tevas-granix-tbo-filgrastim-injection-for-self-administration/2024-11-16T00:21:31+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-goldman-sachs-healthcare-ceos-unscripted-conference2/2024-11-16T00:21:32+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-fda-approval-of-qnasl-beclomethasone-dipropionate-nasal-aerosol-for-treatment-of-childr/2024-11-16T00:21:33+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-provides-2015-business-outlook/2024-11-16T00:21:33+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-first-generic-celebrex-capsules-in-the-united-states/2024-11-16T00:21:34+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-host-2015-business-outlook-conference-call-and-webcast-on-december-11-2014/2024-11-16T00:21:35+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-generic-exforge-hct-tablets-in-the-united-states/2024-11-16T00:21:36+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/prof.-yitzhak-peterburg-elected-chairman-of-tevas-board-of-directors2024-11-16T00:21:37+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-launches-liquid-formulation-of-treanda-bendamustine-hci-injection-in-u.s2024-11-16T00:21:38+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-presents-positive-safety-and-efficacy-data-for-qnasl-beclomethasone-dipropionate-nasal-aerosol-in/2024-11-16T00:21:39+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-presents-data-for-investigational-short-acting-beta-agonist-inhaler-albuterol-mdpi-at-2014-annual-/2024-11-16T00:21:40+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-active-biotech-announce-expansion-of-laquinimod-clinical-development-program-with-new-trial-in-p/2024-11-16T00:21:40+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-university-college-london-embark-on-unique-brain-imaging-study-aimed-at-unlocking-a-new-approach/2024-11-16T00:21:41+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-positive-top-line-results-from-phase-iii-trials-evaluating-fluticasone-propionatesalmeterol/2024-11-16T00:21:42+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-jefferies-autumn-2015-global-healthcare-conference/2024-11-16T00:21:43+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-breakthrough-therapy-designation-for-sd-809-granted-by-fda-for-the-treatment-of-tardive-dy/2024-11-16T00:21:44+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-new-respiratory-data-at-the-2015-annual-scientific-meeting-of-the-american-college-of-all/2024-11-16T00:21:45+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-third-quarter-2015-results/2024-11-16T00:21:46+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-host-third-quarter-2015-financial-results-conference-call-and-webcast-on-october-29-2015/2024-11-16T00:21:47+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-exclusive-launch-of-generic-avodart-capsules-in-the-united-states/2024-11-16T00:21:47+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-approval-of-three-times-a-week-copaxone-40-mgml-in-russia-for-the-treatment-of-relapsing/2024-11-16T00:21:48+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reinforces-focus-on-advancing-multiple-sclerosis-treatment-at-31st-ectrims-congress/2024-11-16T00:21:49+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-accelerates-its-emerging-markets-growth-strategy-with-the-acquisition-of-rimsa-a-leading-independen/2024-11-16T00:21:50+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/important-new-data-from-tevas-tev-48125-phase-2b-migraine-program-published-in-lancet-neurology-in-back-/2024-11-16T00:21:51+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reinforces-leadership-position-in-respiratory-with-acquisition-of-gecko-health-innovations/2024-11-16T00:21:51+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-fda-acceptance-of-a-supplemental-new-drug-application-for-proair-respiclick-albuterol-su/2024-11-16T00:21:52+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-pharmaceuticals-and-ibm-partner-to-build-global-e-health-solutions-on-the-ibm-watson-health-cloud/2024-11-16T00:21:53+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-introduces-design-for-dialogue-to-support-patient-doctor-conversations-on-responsible-pain-managem/2024-11-16T00:21:54+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-u.s.-availability-of-zecuity-sumatriptan-iontophoretic-transdermal-system-first-and-on2024-11-16T00:21:55+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-fda-acceptance-of-nda-for-sd-809-for-treatment-in-huntington-disease/2024-11-16T00:21:56+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-immuneering-announce-tevas-purchase-of-51-equity-share-of-genomic-analysis-company/2024-11-16T00:21:57+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-secures-$33.75-billion-financing-commitment2024-11-16T00:21:58+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-strong-second-quarter-2015-results-and-raises-guidance-for-full-year-2015/2024-11-16T00:21:58+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-preliminary-second-quarter-2015-results/2024-11-16T00:21:59+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-withdraws-proposal-to-acquire-mylan/2024-11-16T00:22:00+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-acquire-allergan-generics-for-$40.5-billion-creating-a-transformative-generics-and-specialty-comp2024-11-16T00:22:01+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-parenteral-medicines-initiates-voluntary-nationwide-recall-of-select-lots-of-adrucil-fluorouracil-/2024-11-16T00:22:02+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-issues-statement/2024-11-16T00:22:03+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-launches-educational-initiative-to-arm-women-with-facts-about-emergency-contraception/2024-11-16T00:22:03+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-report-second-quarter-2015-financial-results-on-july-30-2015/2024-11-16T00:22:04+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-first-to-receive-approval-and-launch-generic-axert-tablets-in-the-united-states/2024-11-16T00:22:05+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-launches-generic-aggrenox-capsules-in-the-united-states/2024-11-16T00:22:06+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-xenon-provide-update-on-tv-45070-phase-2b-study-in-osteoarthritis-pain/2024-11-16T00:22:07+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-active-biotech-announce-completion-of-patient-enrollment-in-laquinimod-phase-iii-concerto-trial/2024-11-16T00:22:07+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-launches-painmatters.com-to-support-responsible-pain-management2024-11-16T00:22:08+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-completes-the-purchase-of-4.61-percent-interest-in-mylan-n.v2024-11-16T00:22:09+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-new-findings-at-the-american-headache-society-ahs-meeting--analysis-of-migraine-phase-/2024-11-16T00:22:10+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-microchips-biotech-announce-partnership-to-enhance-patient-outcomes-through-digital-drug-deliver/2024-11-16T00:22:11+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-advances-pipeline-of-movement-disorder-assets-with-announcement-of-positive-top-line-data-from-the-f/2024-11-16T00:22:12+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-fda-acceptance-of-the-biologics-license-application-for-reslizumab/2024-11-16T00:22:12+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-goldman-sachs-36th-annual-global-healthcare-conference/2024-11-16T00:22:13+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-enhances-adhd-product-line-with-generic-intuniv-in-the-united-states/2024-11-16T00:22:14+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-exclusive-launch-of-generic-actonel-tablets-in-the-united-states/2024-11-16T00:22:15+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-enhances-extensive-womens-health-portfolio-with-launch-of-generic-lomedia24-fe-tablets/2024-11-16T00:22:16+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/jack-osbourne-and-teva-launch-enhanced-you-dont-know-jack-about-ms-website-featuring-new-multimedia-con/2024-11-16T00:22:17+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-new-respiratory-data-at-2015-annual-international-meeting-of-the-american-thoracic-societ/2024-11-16T00:22:17+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-presents-further-data-from-phase-iib-with-tev-48125-in-chronic-migraine-at-the-international-headach/2024-11-16T00:22:18+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-bank-of-america-merrill-lynch-2015-health-care-conference/2024-11-16T00:22:19+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-completes-acquisition-of-auspex-pharmaceuticals/2024-11-16T00:22:20+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-provides-additional-detail-on-proposed-acquisition-of-mylan/2024-11-16T00:22:21+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-first-quarter-2015-results/2024-11-16T00:22:22+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-sends-letter-to-mylan-board/2024-11-16T00:22:22+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-fda-acceptance-of-new-drug-applications-for-fluticasone-propionatesalmeterol-and-fluticas/2024-11-16T00:22:23+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-antares-pharma-announce-launch-of-generic-imitrex-in-the-united-states/2024-11-16T00:22:24+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-receives-chmp-positive-opinion-for-cinqaero-reslizumab/2024-11-16T00:22:25+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-settles-patent-litigation-with-astrazeneca-allowing-teva-to-commercialize-its-generic-version-of-bye/2024-11-16T00:22:26+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-ceo-erez-vigodman-speaks-at-2016-selectusa-investment-summit/2024-11-16T00:22:26+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-data-highlighting-sd-809-at-20th-international-congress-of-parkinsons-disease-and-moveme/2024-11-16T00:22:27+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-voluntary-suspension-of-marketing-for-zecuity-in-the-u.s2024-11-16T00:22:28+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-favorable-court-ruling-in-treanda-bendamustine-hydrochloride-patent-infringement-litiga/2024-11-16T00:22:29+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-gains-recommendation-for-approval-from-fda-advisory-committees-for-vantrela-er-hydrocodone-bitartr/2024-11-16T00:22:30+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-jefferies-2016-healthcare-conference/2024-11-16T00:22:30+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-goldman-sachs-37th-annual-global-healthcare-conference/2024-11-16T00:22:31+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-bernstein-32nd-annual-strategic-decisions-conference/2024-11-16T00:22:32+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-bernstein-32nd-annual-strategic-decisions-conference2/2024-11-16T00:22:33+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-receives-complete-response-letter-for-nda-for-sd-809-for-the-treatment-of-chorea-associated-with-hun/2024-11-16T00:22:34+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-new-data-at-the-2016-american-thoracic-society-ats-international-conference/2024-11-16T00:22:35+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-bank-of-america-merrill-lynch-2016-health-care-conference/2024-11-16T00:22:36+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-first-quarter-2016-results/2024-11-16T00:22:37+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-breathes-its-way-to-a-guinness-world-records-title/2024-11-16T00:22:38+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-fda-approval-of-proair-respiclick-albuterol-sulfate-inhalation-powder-for-pediatric-ast/2024-11-16T00:22:38+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/jennifer-morrison-reveals-how-her-journey-with-migraine-is-more-than-a-headache/2024-11-16T00:22:39+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-report-first-quarter-2016-financial-results-on-may-9-2016/2024-11-16T00:22:40+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-presents-new-data-for-sd-809-in-huntington-disease-at-68th-american-academy-of-neurology-aan-annua/2024-11-16T00:22:41+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-data-highlighting-companys-pipeline-in-neurological-disorders-at-68th-aan-annual-meeting/2024-11-16T00:22:42+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-fda-approval-of-cinqair-reslizumab-injection/2024-11-16T00:22:43+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-generic-campral-in-the-united-states/2024-11-16T00:22:44+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-barclays-global-healthcare-conference2/2024-11-16T00:22:45+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-receives-european-commission-approval-for-the-allergan-generics-acquisition/2024-11-16T00:22:45+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-pharmaceuticals-initiates-voluntary-nationwide-recall-of-one-lot-of-amikacin-sulfate-injection-usp-1/2024-11-16T00:22:46+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-completes-generic-pulmicort-respules-portfolio-with-the-launch-of-third-strength-in-the-united-stat/2024-11-16T00:22:47+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-completes-acquisition-of-rimsa/2024-11-16T00:22:48+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-new-respiratory-data-at-the-2016-academy-of-allergy-asthma-and-immunology-annual-meeting/2024-11-16T00:22:49+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-cowen--company-36th-annual-healthcare-conference/2024-11-16T00:22:49+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-pharmaceuticals-embarks-on-strategic-corporate-identity-program-to-build-a-global-brand/2024-11-16T00:22:50+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-files-2015-annual-report-on-form20-f/2024-11-16T00:22:51+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-full-year-2015-and-fourth-quarter-financial-results/2024-11-16T00:22:52+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-abcellera-enter-into-agreement-to-discover-rare-monoclonal-antibodies/2024-11-16T00:22:53+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-eagle-pharmaceuticals-announce-commercial-availability-of-bendeka-bendamustine-hydrochloride-/2024-11-16T00:22:53+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-report-fourth-quarter-2015-financial-results-on-february-11-2016/2024-11-16T00:22:54+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-releases-innovation-and-social-responsibility-highlights/2024-11-16T00:22:55+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-checkpoint-therapeutics-announce-license-agreement-for-oral-parp-inhibitor/2024-11-16T00:22:56+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-34th-annual-j.p.-morgan-healthcare-conference2024-11-16T00:22:57+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-generic-ortho-tri-cyclen-lo-in-the-united-states/2024-11-16T00:22:58+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-active-biotech-announce-discontinuation-of-higher-doses-of-laquinimod-in-two-multiple-sclerosis-/2024-11-16T00:22:59+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-exercise-of-underwriters-over-allotment-option/2024-11-16T00:23:00+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/fda-advisory-committee-recommends-approval-of-tevas-asthma-biologic-reslizumab/2024-11-16T00:23:00+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-closing-of-public-offerings-of-american-depositary-shares-and-mandatory-convertible-prefer/2024-11-16T00:23:01+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-pharmaceuticals-and-eagle-pharmaceuticals-announce-fda-approval-of-bendeka-bendamustine-hydrochlor/2024-11-16T00:23:02+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-pricing-of-public-offerings-of-american-depositary-shares-and-mandatory-convertible-prefer/2024-11-16T00:23:03+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-proposed-public-offerings-of-american-depositary-shares-and-mandatory-convertible-preferre/2024-11-16T00:23:04+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-heptares-enter-agreement-to-discover-and-develop-novel-small-molecule-cgrp-antagonists-for-trea/2024-11-16T00:23:05+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-confirms-generic-victoza-patent-challenge-in-the-united-states/2024-11-16T00:23:05+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-report-fourth-quarter-2016-financial-results-on-february-13-2017/2024-11-16T00:23:06+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-confirms-district-court-decision-in-copaxone-40-mgml-patent-trial/2024-11-16T00:23:07+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-fda-approval-of-two-new-respiclick-maintenance-inhalers-for-the-treatment-of-asthma/2024-11-16T00:23:08+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-receives-fda-approval-for-vantrelatm-er-hydrocodone-bitartrate-extended-release-tablets-cii-form/2024-11-16T00:23:09+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-completion-of-sale-of-uk-and-ireland-actavis-assets-and-operations-following-european-comm/2024-11-16T00:23:09+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-35th-annual-j.p.-morgan-healthcare-conference2024-11-16T00:23:11+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-provides-2017-financial-outlook/2024-11-16T00:23:12+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-host-2017-business-outlook-conference-call-and-webcast-on-january-6-2017/2024-11-16T00:23:13+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reaches-settlement-with-government-on-fcpa/2024-11-16T00:23:14+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-womens-health-inc.-and-kinsey-institute-at-indiana-university-survey-reveals-u.s.college-students2024-11-16T00:23:15+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-citi-2016-global-healthcare-conference/2024-11-16T00:23:15+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-appoints-dipankar-bhattacharjee-as-president-and-chief-executive-officer-global-generic-medicines-g/2024-11-16T00:23:16+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-oncology-data-at-the-2016-american-society-of-hematology-ash-annual-meeting--expositio/2024-11-16T00:23:17+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-third-quarter-2016-results/2024-11-16T00:23:18+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-appointment-of-new-chief-legal-officer/2024-11-16T00:23:19+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-approval-of-generic-tribenzor-in-the-united-states/2024-11-16T00:23:19+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-highlights-growing-respiratory-portfolio-at-the-2016-american-college-of-allergy-asthma--immunolog/2024-11-16T00:23:20+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/cms-establishes-unique-j-code-for-bendeka-bendamustine-hydrochloride-injection/2024-11-16T00:23:21+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-report-third-quarter-2016-financial-results-on-november-15-2016/2024-11-16T00:23:22+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-pharmaceuticals-and-ibm-expand-global-partnership-to-enable-drug-development-and-chronic-disease-man/2024-11-16T00:23:23+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-fda-acceptance-of-resubmitted-new-drug-application-for-sd-809-for-treatment-of-chorea-asso/2024-11-16T00:23:24+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/regeneron-and-teva-provide-update-on-fasinumab-clinical-development-programs/2024-11-16T00:23:25+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-generic-beyaz-in-the-united-states/2024-11-16T00:23:25+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-celltrion-announce-exclusive-biosimilar-commercial-partnership/2024-11-16T00:23:26+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-sale-of-uk-and-ireland-actavis-assets-and-operations/2024-11-16T00:23:27+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-completes-acquisition-of-anda-inc/2024-11-16T00:23:28+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-generic-epzicom-tablets-in-the-united-states/2024-11-16T00:23:29+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-positive-top-line-data-from-second-phase-iii-study-of-sd-809-in-tardive-dyskinesia-td/2024-11-16T00:23:29+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-regeneron-announce-global-collaboration-to-develop-and-commercialize-fasinumab-an-investigation/2024-11-16T00:23:30+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-results-from-exploratory-52-week-phase-2-pride-hd-study-of-pridopidine-in-huntington-disea/2024-11-16T00:23:31+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-strengthens-injectables-portfolio-with-the-launch-of-an-authorized-generic-of-cubicin-daptomycin-f/2024-11-16T00:23:32+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/national-business-group-on-health-honors-teva-pharmaceuticals-with-best-employers-for-healthy-lifestyles/2024-11-16T00:23:33+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-develop-unique-wearable-tech-and-machine-learning-platform-for-continuous-measurement--analysis-/2024-11-16T00:23:34+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-latest-data-in-multiple-sclerosis-at-2016-ectrims-congress-in-london/2024-11-16T00:23:34+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-wells-fargo-2016-healthcare-conference/2024-11-16T00:23:35+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-host-generic-medicines-business-overview-on-september-9-2016/2024-11-16T00:23:36+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-confirms-ptabs-decisions-on-two-patents-in-ipr-challenge-to-copaxone-40-mg/2024-11-16T00:23:36+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-generic-gleevec-tablets-in-the-united-states/2024-11-16T00:23:37+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-second-quarter-2016-results/2024-11-16T00:23:38+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-acquisition-of-anda-inc/2024-11-16T00:23:39+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-completes-acquisition-of-actavis-generics/2024-11-16T00:23:40+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/correcting-and-replacing-teva-pharmaceuticals-initiates-voluntary-nationwide-recall-of-seven-lots-of-amik/2024-11-16T00:23:40+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-report-second-quarter-2016-financial-results-on-august-4-2016/2024-11-16T00:23:41+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-receives-clearance-from-the-u.s.-federal-trade-commission-for-actavis-generics-acquisition2024-11-16T00:23:42+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-pricing-of-additional-chf1.0-billion-of-senior-notes-in-connection-with-pending-acquisitio2024-11-16T00:23:43+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-pricing-of-additional-4.0-billion-of-senior-notes-in-connection-with-pending-acquisition-2024-11-16T00:23:44+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-pricing-of-$15-billion-of-senior-notes-in-connection-with-pending-acquisition-of-actavis-g/2024-11-16T00:23:45+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-host-conference-call-and-webcast-to-provide-preliminary-outlook-for-2016-2019/2024-11-16T00:23:45+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-the-huntington-study-group-announce-publication-of-pivotal-phase-iii-data-on-deutetrabenazine-s/2024-11-16T00:23:46+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/new-initiative-creates-scalable-solutions-to-improve-care-of-patients-with-multiple-chronic-conditions/2024-11-16T00:23:47+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-sale-of-remaining-assets-in-specialty-global-womens-health-portfolio-for-$1.38-billion2024-11-16T00:23:48+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-data-for-austedo-deutetrabenazine-tablets-and-other-research-at-the-2017-psych-congres/2024-11-16T00:23:48+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-receives-fda-priority-review-for-first-line-use-of-trisenox-arsenic-trioxide-in-patients-with-low/2024-11-16T00:23:49+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-sale-of-paragard-intrauterine-copper-contraceptive-to-coopersurgical/2024-11-16T00:23:50+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-names-kare-schultz-as-president-and-chief-executive-officer/2024-11-16T00:23:51+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-showcases-data-demonstrating-potential-of-fremanezumab-to-address-significant-unmet-need-in-patients/2024-11-16T00:23:52+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-fremanezumab-data-on-migraine-prevention-at-the-18th-congress-of-the-international-headac/2024-11-16T00:23:53+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-fda-approval-of-austedo-deutetrabenazine-tablets-for-the-treatment-of-tardive-dyskinesi/2024-11-16T00:23:54+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-exclusive-launch-of-generic-axiron-in-the-united-states/2024-11-16T00:23:54+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-fda-approval-of-qvar-redihaler-beclomethasone-dipropionate-hfa-inhalation-aerosol/2024-11-16T00:23:55+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-second-quarter-2017-financial-results/2024-11-16T00:23:56+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/celltrion-and-teva-announce-u.s.-fda-acceptance-of-biologics-license-application-for-proposed-biosimilar-2024-11-16T00:23:57+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-generic-epiduo-in-the-united-states/2024-11-16T00:23:58+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-the-launch-of-generic-vagifem-in-the-united-states/2024-11-16T00:23:59+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/nice-recommends-cinqaero-reslizumab-for-the-treatment-of-severe-eosinophilic-asthma/2024-11-16T00:23:59+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-enhances-board-of-directors-as-all-proposals-approved-at-annual-general-meeting-of-shareholders/2024-11-16T00:24:00+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-report-second-quarter-2017-financial-results-on-august-3-2017/2024-11-16T00:24:01+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-the-huntington-study-group-announce-publication-of-data-for-austedo-deutetrabenazine-tablets-/2024-11-16T00:24:02+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/celltrion-and-teva-announce-u.s2.-fda-acceptance-of-biologics-license-application-for-proposed-biosimilar-2024-11-16T00:24:03+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-publication-of-aim-td-study-results-in-the-lancet-psychiatry-for-the-investigational-use-o/2024-11-16T00:24:04+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-xenon-announce-phase-ii-study-of-topical-tv-45070-in-patients-with-post-herpetic-neuralgia-phn/2024-11-16T00:24:05+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-pharmaceuticals-usa-extends-voluntary-nationwide-recall-to-consumeruser-level-for-one-lot-of-palip/2024-11-16T00:24:06+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-generic-zetia-in-the-united-states/2024-11-16T00:24:07+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-exclusive-launch-of-generic-pataday-in-the-united-states/2024-11-16T00:24:08+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/tevas-fremanezumab-meets-all-primary--secondary-endpoints-across-both-monthly-and-quarterly-dosing-regi/2024-11-16T00:24:08+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-jefferies-2017-global-healthcare-conference/2024-11-16T00:24:09+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-data-from-18-abstracts-in-tardive-dyskinesia-and-huntington-disease-at-the-21st-internati/2024-11-16T00:24:10+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-positive-results-for-phase-iii-study-of-fremanezumab-for-the-prevention-of-chronic-migrain/2024-11-16T00:24:11+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-showcases-asthma-research-at-the-2017-american-thoracic-society-ats-international-conference/2024-11-16T00:24:11+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-data-for-deutetrabenazine-in-tardive-dyskinesia-at-the-american-psychiatric-association-2/2024-11-16T00:24:12+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-generic-glumetza-in-the-united-states/2024-11-16T00:24:13+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-first-quarter-2017-financial-results/2024-11-16T00:24:14+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-active-biotech-announce-concerto-trial-of-laquinimod-in-rrms-did-not-meet-primary-endpoint/2024-11-16T00:24:15+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-publication-of-copaxone-glatiramer-acetate-injection-pregnancy-data-in-the-internationa/2024-11-16T00:24:16+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-publication-of-arm-td-study-results-in-neurology-for-the-investigational-use-of-deutetrab/2024-11-16T00:24:17+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-generic-vytorin-in-the-united-states/2024-11-16T00:24:18+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-planned-departure-of-eyal-desheh-group-executive-vice-president-and-chief-financial-offic/2024-11-16T00:24:19+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-launches-airduo-respiclick-and-its-authorized-generic-two-inhalers-containing-fluticasone-propion/2024-11-16T00:24:20+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-showcases-cns-portfolio-at-69th-annual-meeting-of-the-american-academy-of-neurology/2024-11-16T00:24:21+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-report-first-quarter-2017-financial-results-on-may-11-2017/2024-11-16T00:24:22+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-fda-approval-of-austedo-deutetrabenazine-tablets-for-the-treatment-of-chorea-associated/2024-11-16T00:24:23+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-authorized-generic-of-minastrin-24-fe-norethindrone-acetate-and-ethinyl-estrad/2024-11-16T00:24:24+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-barclays-global-annual-healthcare-conference/2024-11-16T00:24:25+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-cowen--company-37th-annual-healthcare-conference/2024-11-16T00:24:26+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-generic-pristiq-in-the-united-states/2024-11-16T00:24:26+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-priority-review-granted-by-fda-for-sd-809-for-treatment-of-tardive-dyskinesia/2024-11-16T00:24:27+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-files-2016-annual-report-on-form20-f/2024-11-16T00:24:28+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-full-year-and-fourth-quarter-2016-financial-results/2024-11-16T00:24:29+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-appoints-dr.-yitzhak-peterburg-as-interim-chief-executive-officer-succeeding-erez-vigodman2024-11-16T00:24:30+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-provides-update-on-clinical-trial-of-fremanezumab-for-use-in-chronic-cluster-headache/2024-11-16T00:24:31+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-confirms-september-pdufa-date-for-fremanezumab/2024-11-16T00:24:32+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/correcting-and-replacing-teva-announces-publication-of-phase-iii-trial-data-of-fremanezumab-for-the-preve/2024-11-16T00:24:33+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-first-quarter-2018-financial-results/2024-11-16T00:24:34+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-austedo-deutetrabenazine-tablets-data-at-the-american-psychiatric-association-2018-ann/2024-11-16T00:24:35+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-presents-new-long-term-data-demonstrating-efficacy-and-safety-of-copaxone-glatiramer-acetate-injec/2024-11-16T00:24:36+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-report-first-quarter-2018-financial-results-on-may-3-2018/2024-11-16T00:24:36+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-the-procter--gamble-company-have-agreed-to-terminate-the-pgt-healthcare-partnership/2024-11-16T00:24:37+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-new-data-across-multiple-therapeutic-areas-at-70th-annual-meeting-of-the-american-academy/2024-11-16T00:24:38+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-the-launch-of-a-generic-version-of-lialda-in-the-united-states/2024-11-16T00:24:39+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-the-launch-of-a-generic-version-of-aloxi-in-the-united-states/2024-11-16T00:24:40+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-cowen--company-38th-annual-healthcare-conference/2024-11-16T00:24:41+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-upsizing-and-successful-pricing-of-$4.5-billion-of-senior-notes2024-11-16T00:24:41+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-offering-of-senior-notes/2024-11-16T00:24:42+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-exclusive-launch-of-two-strengths-of-a-generic-version-of-solodyn-in-the-united-states/2024-11-16T00:24:43+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-u.s.-launch-of-qvar-redihaler-beclomethasone-dipropionate-hfa-inhalation-aerosol2024-11-16T00:24:44+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-a-generic-version-of-syprine-in-the-united-states/2024-11-16T00:24:45+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-2017-full-year-and-fourth-quarter-financial-results/2024-11-16T00:24:46+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/new-survey-highlights-misconceptions-about-family-planning-among-women-with-relapsing-forms-of-multiple-s/2024-11-16T00:24:47+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-completes-amendment-to-credit-facilities/2024-11-16T00:24:48+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-completion-of-global-womens-health-divestiture-to-cvc-capital-partners/2024-11-16T00:24:49+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2017-financial-results-at-8-a.m.-et-2024-11-16T00:24:49+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-top-line-results-from-phase-iii-studies-of-subcutaneously-administered-reslizumab-in-patie/2024-11-16T00:24:50+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-u.s.-fda-approval-of-trisenox-arsenic-trioxide-injection-for-first-line-treatment-of-ac2024-11-16T00:24:52+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-global-license-agreement-with-alder-biopharmaceuticals-in-the-field-of-anti-cgrp-based-th/2024-11-16T00:24:53+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-36th-annual-j.p.-morgan-healthcare-conference2024-11-16T00:24:53+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-an-authorized-generic-of-estrace-cream-in-the-united-states/2024-11-16T00:24:54+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-exclusive-launch-of-a-generic-version-of-reyataz-in-the-united-states/2024-11-16T00:24:55+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/fda-accepts-biologics-license-application-for-fremanezumab-with-priority-review-for-prevention-of-migrain/2024-11-16T00:24:56+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-exclusive-launch-of-generic-viread-in-the-united-states/2024-11-16T00:24:57+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-restructuring-plan-and-additional-measures-to-improve-its-business-and-financial-performan/2024-11-16T00:24:58+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-host-conference-call-to-discuss-restructuring-plan-and-additional-measures-to-improve-its-busines/2024-11-16T00:24:59+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-exclusive-launch-of-generic-viagra-tablets-in-the-united-states/2024-11-16T00:25:00+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/the-new-england-journal-of-medicine-publishes-data-from-pivotal-phase-iii-trial-of-fremanezumab-for-the-p/2024-11-16T00:25:01+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-new-organization-structure-and-leadership-changes/2024-11-16T00:25:02+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-prescription-copay-savings-program-for-generic-gleevec-tablets-in-the-united-states/2024-11-16T00:25:03+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/national-survey-reveals-majority-of-women-newly-diagnosed-with-multiple-sclerosis-have-concerns-they-aren/2024-11-16T00:25:04+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-completion-of-plan-b-one-step-divestiture-to-foundation-consumer-healthcare/2024-11-16T00:25:04+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-third-quarter-2017-financial-results/2024-11-16T00:25:05+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-completion-of-paragard-divestiture-to-coopersurgical/2024-11-16T00:25:06+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-wins-generic-uceris-patent-trial/2024-11-16T00:25:07+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/kare-schultz-to-join-teva-as-president-and-chief-executive-officer-on-november-1-2017/2024-11-16T00:25:08+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-highlight-asthma-data-at-the-2017-american-college-of-allergy-asthma-and-immunology-annual-scien/2024-11-16T00:25:08+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-highlight-new-data-in-multiple-sclerosis-at-joint-ectrims--actrims-congress-in-paris/2024-11-16T00:25:09+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-submission-of-biologics-license-application-for-fremanezumab-to-the-u.s.-fda2024-11-16T00:25:10+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-report-third-quarter-2017-financial-results-on-november-2-2017/2024-11-16T00:25:11+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-comments-on-anticipated-at-risk-u.s.-launch-of-generic-glatiramer-acetate-40mgml-and-launch-of-gene2024-11-16T00:25:12+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-reintroduction-of-generic-depo-provera-in-the-united-states/2024-11-16T00:25:13+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-nuvelution-pharma-partner-to-accelerate-development-of-austedo-deutetrabenazine-tablets-for-u/2024-11-16T00:25:13+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-completes-amendment-to-credit-facilities2/2024-11-16T00:25:14+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-a-generic-version-of-tarcevaerlotinib-tablets-in-the-united-states/2024-11-16T00:25:15+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-new-long-term-data-on-efficacy-and-safety-of-fremanezumab-at-2019-american-academy-of-neu/2024-11-16T00:25:16+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-first-quarter-2019-financial-results/2024-11-16T00:25:17+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-a-generic-version-of-letairis-ambrisentan-tablets-in-the-united-states/2024-11-16T00:25:17+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-new-central-nervous-system-portfolio-data-at-71st-annual-meeting-of-the-american-academy-/2024-11-16T00:25:18+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-pharmaceuticals-usa-inc.-issues-voluntary-nationwide-recall-of-losartan-potassium-25-mg-and-100-mg-2024-11-16T00:25:19+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-update-on-fremanezumab-clinical-development-for-use-in-episodic-cluster-headache/2024-11-16T00:25:20+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-a-generic-version-of-vesicaresolifenacin-succinatetablets-in-the-united-sta/2024-11-16T00:25:21+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-a-generic-version-of-androgel-testosterone-gel-1.62-ciii-in-the-united-state2024-11-16T00:25:22+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-signs-new-$2.3-billion-syndicated-revolving-credit-facility2024-11-16T00:25:23+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-host-conference-call-to-discuss-first-quarter-2019-financial-results-at-8-a.m.-et-on-may-2-20192024-11-16T00:25:24+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/tevas-ajovy-receives-eu-approval-offering-patients-the-first-and-only-anti-cgrp-treatment-with-both-qua/2024-11-16T00:25:25+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/tevas-copaxone-40mg--favorable-response-from-european-patent-office/2024-11-16T00:25:26+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-a-generic-version-of-exjade-deferasirox-tablets-for-oral-suspension-in-the-un/2024-11-16T00:25:27+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/update-on-COVID-19/2024-11-16T00:25:28+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-an-authorized-generic-of-flector-patch-diclofenac-epolamine-topical-patch-in-/2024-11-16T00:25:29+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-finalizes-settlement-with-federal-trade-commission-to-resolve-all-outstanding-litigation-between-the/2024-11-16T00:25:30+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-fourth-quarter-and-full-year-2018-financial-results/2024-11-16T00:25:31+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-u.s.-launch-of-a-generic-version-of-sabril-vigabatrin2024-11-16T00:25:32+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-alyq-tadalafil-tablets-usp-a-generic-version-of-adcirca-in-the-united-state/2024-11-16T00:25:33+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-receives-positive-committee-for-medicinal-products-for-human-use-chmp-opinion-for-ajovy-fremanez/2024-11-16T00:25:34+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2018-financial-results-at-8-a.m.-et-2024-11-16T00:25:35+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-37th-annual-j.p.-morgan-healthcare-conference2024-11-16T00:25:36+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-amgen-resolve-ongoing-dispute-over-tevas-generic-cinacalet-hcl-product/2024-11-16T00:25:37+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-us-launch-of-a-generic-version-of-elidel-pimecrolimus-cream-1/2024-11-16T00:25:38+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/adding-multimedia-teva-announces-fda-approval-of-first-and-only-digital-inhaler-with-built-in-sensors--p/2024-11-16T00:25:39+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-positive-topline-phase-iiib-results-with-fremanezumab-in-adults-with-migraine-who-did-not-/2024-11-16T00:25:40+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/celltrion-and-teva-announce-fda-approval-of-herzuma-trastuzumab-pkrb-a-biosimilar-to-herceptin-for-/2024-11-16T00:25:41+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/celltrion-and-teva-announce-fda-approval-of-truxima-rituximab-abbs-a-biosimilar-to-rituxan-for-thre/2024-11-16T00:25:42+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/tevas-generic-version-of-epipenepinephrine-injection-usp-auto-injector-0.3-mg-now-available-in-limi2024-11-16T00:25:43+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/tevas-generic-version-of-epipen-epinephrine-injection-usp-auto-injector-0.3-mg-now-available-in-limi2024-11-16T00:25:43+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-third-quarter-2018-financial-results/2024-11-16T00:25:45+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-new-jersey-governor-murphy-formalize-north-america-headquarters-move-with-ceremony-in-israel/2024-11-16T00:25:46+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/celltrion-and-teva-announce-fda-oncologic-drugs-advisory-committee-recommends-approval-of-celltrion-bla-f/2024-11-16T00:25:47+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-presents-25-year-safety-data-from-longest-continuous-trial-of-copaxone-glatiramer-acetate-injectio/2024-11-16T00:25:48+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-report-third-quarter-2018-financial-results-on-november-1-2018/2024-11-16T00:25:49+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-exclusive-first-to-file-launch-of-a-generic-version-of-cialis-in-the-united-states/2024-11-16T00:25:50+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-early-results-of-debt-tender-offer-and-election-of-early-settlement/2024-11-16T00:25:50+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/adding-multimedia-teva-announces-u.s.-approval-of-ajovytm-fremanezumab-vfrm-injection-the-first-and-on2024-11-16T00:25:51+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-morgan-stanley-global-healthcare-conference2/2024-11-16T00:25:52+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-appoints-john-nason-president-tapi-and-biologics-operations/2024-11-16T00:25:53+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-$400-million-debt-tender-offer/2024-11-16T00:25:54+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/statement-united-states-food-and-drug-administration-approves-tevas-generic-epinephrine-injection-auto-/2024-11-16T00:25:55+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-regeneron-announce-positive-topline-phase-3-fasinumab-results-in-patients-with-chronic-pain-from/2024-11-16T00:25:56+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-updated-indication-and-vial-presentation-for-granix-tbo-filgrastim-injection-in-united-/2024-11-16T00:25:57+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-second-quarter-2018-financial-results/2024-11-16T00:25:58+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-highlights-key-milestones-achieved-in-the-2017-social-impact-report/2024-11-16T00:25:59+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-pharmaceuticals-usa-issues-voluntary-nationwide-recall-of-valsartan-and-valsartan-hydrochlorothiazid/2024-11-16T00:26:00+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-report-second-quarter-2018-financial-results-on-august-2-2018/2024-11-16T00:26:01+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-a-generic-version-of-uceris-in-the-united-states/2024-11-16T00:26:02+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-new-fremanezumab-data-including-long-term-data-at-the-american-headache-societys-60th-/2024-11-16T00:26:03+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-showcases-global-impact-in-2019-environmental-social-and-governance-progress-report/2025-06-16T09:15:15+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-virtual-2020-annual-meeting-of-shareholders/2024-11-16T00:26:05+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-presented-new-data-at-the-european-academy-of-neurology-congress-evaluating-the-ajovy-fremanezumab/2024-11-16T00:26:06+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-new-ajovy-fremanezumab-analyses-and-latest-copaxone-data-glatiramer-acetate-injectio/2024-11-16T00:26:07+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/china-approves-austedo-for-treating-chorea-associated-with-huntingtons-disease-and-tardive-dyskinesia-i/2024-11-16T00:26:08+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-first-quarter-2020-financial-results/2024-11-16T00:26:09+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-celltrion-healthcare-announce-the-launch-of-truxima-rituximab-abbs-injection-for-rheumatoid-a/2024-11-16T00:26:10+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/new-data-for-teva-ajovy-fremanezumab-vfrm-injection-and-austedo-deutetrabenazine-tablets-included-i/2024-11-16T00:26:10+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-u.s.-launch-of-autoinjector-for-ajovy-fremanezumab-vfrm-injection2024-11-16T00:26:12+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-host-conference-call-to-discuss-first-quarter-2020-financial-results-at-8-a.m.-et-on-may-7-20202024-11-16T00:26:13+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-donate-potential-covid-19-treatment-hydroxychloroquine-sulfate-tablets-to-hospitals-nationwide/2024-11-16T00:26:14+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-celltrion-healthcare-announce-u.s.-availability-of-herzuma-trastuzumab-pkrb-for-injection2024-11-16T00:26:14+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/positive-recommendation-by-nice-for-first-anti-cgrp-migraine-therapy-ajovy-fremanezumab/2024-11-16T00:26:15+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-fda-approval-of-armonair-digihaler-fluticasone-propionate-inhalation-powder/2024-11-16T00:26:16+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-registration-trials-of-deutetrabenazine-in-pediatric-patients-with-tourette-syndrome-did-n/2024-11-16T00:26:17+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/new-report-shows-teva-generic-medicines-saved-us-healthcare-system-$41.9-billion2024-11-16T00:26:18+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-fourth-quarter-and-full-year-2019-financial-results/2024-11-16T00:26:19+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-positive-top-line-results-from-ajovy-fremanezumab-clinical-trials-in-japan/2024-11-16T00:26:20+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-fda-approval-of-ajovy-fremanezumab-vfrm-injection-autoinjector/2024-11-16T00:26:21+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-host-conference-call-to-discuss-fourth-quarter-2019-financial-results-and-2020-financial-guidance/2024-11-16T00:26:22+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-38th-annual-j.p.-morgan-healthcare-conference2024-11-16T00:26:22+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-early-tender-results-of-its-debt-tender-offer-and-election-of-early-settlement/2024-11-16T00:26:23+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-successful-upsize-of-senior-notes-offering-and-pricing-of-$2.1-billion-of-senior-notes2024-11-16T00:26:24+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-$1.5-billion-debt-tender-offers2024-11-16T00:26:25+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-$1500000000-offering-of-senior-notes/2024-11-16T00:26:26+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-celltrion-announce-the-availability-of-truxima-rituximab-abbs-injection-the-first-biosimilar/2024-11-16T00:26:27+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-appointment-of-new-chief-financial-officer/2024-11-16T00:26:28+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-third-quarter-2019-financial-results/2024-11-16T00:26:29+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-host-conference-call-to-discuss-third-quarter-2019-financial-results-at-8-a.m.-et-on-november-7-2024-11-16T00:26:30+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-new-analyses-of-fremanezumab-and-country-specific-burden-of-migraine-at-24th-world-congre/2024-11-16T00:26:31+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-settles-track-1-opioid-cases-and-reaches-agreement-on-framework-to-settle-remaining-litigation/2024-11-16T00:26:32+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-new-data-on-austedo-deutetrabenazine-tablets-at-psych-congress-2019/2024-11-16T00:26:33+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-leadership-change-in-its-global-operations-group/2024-11-16T00:26:34+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-united-states-department-of-commerce-appointment-of-brendan-ogrady-to-investment-advisory/2024-11-16T00:26:34+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-new-analyses-of-fremanezumab-efficacy-and-safety-in-adult-patients-with-difficult-to-trea/2024-11-16T00:26:35+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/fremanezumab-data-in-the-lancet-demonstrate-clinically-meaningful-reduction-in-monthly-migraine-days-vers/2024-11-16T00:26:37+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-availability-of-a-generic-equivalent-of-epipen-jr-epinephrine-injection-usp-auto-injec/2024-11-16T00:26:38+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-cfo-leadership-transition/2024-11-16T00:26:39+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-second-quarter-2019-financial-results/2024-11-16T00:26:40+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-fda-approval-of-airduo-digihaler-fluticasone-propionate-113-mcg-and-salmeterol-14-mcg-/2024-11-16T00:26:40+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-completes-facilities-purchase-in-pennsylvania-for-north-america-research--development-campus/2024-11-16T00:26:41+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-new-data-on-ajovy-fremanezumab-vfrm-injection-at-the-american-headache-societys-61st-/2024-11-16T00:26:42+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-host-conference-call-to-discuss-second-quarter-2019-financial-results-at-8-a.m.-et-on-august-7-22024-11-16T00:26:43+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-presents-positive-results-showing-improvement-in-disability-and-quality-of-life-from-the-phase-iiib-/2024-11-16T00:26:44+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-1-sodium-hyaluronate-in-the-united-states/2024-11-16T00:26:45+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-a-generic-version-of-tracleer-bosentan-tablets-in-the-united-states/2024-11-16T00:26:46+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-new-fremanezumab-focus-clinical-study-data-for-the-first-time-at-the-13th-european-headac/2024-11-16T00:26:47+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-a-generic-version-of-ranexa-ranolazine-extended-release-tablets-in-the-united/2024-11-16T00:26:48+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/company-statement-teva-reaches-agreement-with-state-of-oklahoma-to-resolve-states-claims-against-the-co/2024-11-16T00:26:49+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-the-launch-of-a-generic-version-of-delzicol-mesalamine-delayed-release-capsules-in-the-/2024-11-16T00:26:50+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-new-data-on-ajovy-fremanezumab-vfrm-injection-open-label-extension-study-at-american-h/2024-11-16T00:26:51+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-availability-of-proair-digihaler-albuterol-sulfate-117-mcg-inhalation-powder-for-patie/2024-11-16T00:26:52+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-host-conference-call-to-discuss-second-quarter-2020-financial-results-at-8-a.m.-et-on-august-5-22024-11-16T00:26:53+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-presents-new-analyses-examining-changes-in-migraine-disability-outcome-measurements-with-ajovy-fre/2024-11-16T00:26:53+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-new-drug-application-filing-in-japan-for-ajovy-fremanezumab-injection/2024-11-16T00:26:54+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-new-strategic-focus-in-the-japanese-market/2024-11-16T00:26:55+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-second-quarter-2020-financial-results/2024-11-16T00:26:56+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-alvotech-announce-strategic-partnership-to-collaborate-in-the-u.s.-biosimilar-market2024-11-16T00:26:58+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/statement-in-response-to-news-of-the-indictment-of-teva-usa/2024-11-16T00:26:59+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-new-data-on-austedo-deutetrabenazine-tablets-at-the-mds-virtual-congress-2020-and-psyc/2024-11-16T00:27:00+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-new-data-at-the-mds-virtual-congress-2020-and-psych-congress-2020-virtual-experience-eval/2024-11-16T00:27:02+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/first-long-term-data-on-the-use-of-ajovy-fremanezumab-vfrm-injection-in-patients-with-migraine-publish/2024-11-16T00:27:03+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-launches-two-digital-inhalers-in-the-u.s.-airduo-digihaler-fluticasone-propionate-and-salmeterol2024-11-16T00:27:04+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-host-conference-call-to-discuss-third-quarter-2020-financial-results-at-8-a.m.-et-on-november-5-2024-11-16T00:27:05+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-launches-first-generic-versions-of-hiv-1-treatments-truvada-emtricitabine-200-mgtenofovir-disopro/2024-11-16T00:27:06+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-new-analysis-of-consistency-in-migraine-days-over-the-course-of-a-dosing-regimen-for-ajovy/2024-11-16T00:27:07+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-amazon-web-services-and-onica-announce-collaboration-to-support-tevas-digihaler-portfolio/2024-11-16T00:27:08+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-third-quarter-2020-financial-results/2024-11-16T00:27:09+00:00yearly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-39th-annual-j.p.-morgan-healthcare-conference2024-11-16T00:27:10+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-host-conference-call-to-discuss-fourth-quarter-2020-financial-results-and-2021-financial-guidance/2024-11-16T00:27:11+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-medincell-announce-positive-results-for-registration-trial-of-investigational-extended-release-s/2024-11-16T00:27:12+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-a-generic-version-of-nuvaring-etonogestrel-and-ethinyl-estradiol-vaginal-ring/2024-11-16T00:27:13+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-fourth-quarter-and-full-year-2020-financial-results/2024-11-16T00:27:15+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/new-study-published-in-cephalalgia-identifies-mechanistic-differences-among-cgrp-migraine-treatments/2024-11-16T00:27:16+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-j.p.-morgan-2021-global-high-yield-and-leveraged-finance-conference2024-11-16T00:27:17+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-first-generic-version-of-azopt-brinzolamide-ophthalmic-suspension-1-used-to/2024-11-16T00:27:18+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-host-conference-call-to-discuss-first-quarter-2021-financial-results-at-8-a.m.-et-on-april-28-202024-11-16T00:27:19+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-new-analyses-of-ajovy-fremanezumab-vfrm-injection-and-austedo-deutetrabenazine-tabl/2024-11-16T00:27:20+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/new-clinical-and-real-world-data-evaluating-efficacy-of-ajovy-fremanezumab-vfrm-injection-and-reductio/2024-11-16T00:27:21+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-its-generic-version-of-canasa-mesalamine-suppositories-to-treat-adults-with-a/2024-11-16T00:27:22+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-new-analyses-of-austedo-deutetrabenazine-tablets-and-assessment-of-schizophrenia-clini/2024-11-16T00:27:23+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-first-quarter-2021-financial-results/2024-11-16T00:27:24+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-the-launch-of-the-first-generic-version-of-absorica-isotretinoin-capsules-for-the-trea/2024-11-16T00:27:25+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-new-long-term-austedo-deutetrabenazine-tablets-data-at-american-psychiatric-associatio/2024-11-16T00:27:26+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-its-generic-erythromycin-tablets-usp-used-to-treat-or-prevent-a-variety-of-bact/2024-11-16T00:27:27+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-new-environmental-social-and-governance-esg-strategy-and-goals-in-2020-report/2025-06-26T13:49:07+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-highlight-research-in-respiratory-care-at-upcoming-2021-american-thoracic-society-international-c/2024-11-16T00:27:29+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-the-u.s.-launch-of-the-first-generic-version-of-thiola-tiopronin-tablets2024-11-16T00:27:30+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-latest-data-on-ajovy-fremanezumab-vfrm-injection-at-the-2021-american-headache-society/2024-11-16T00:27:30+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/new-clinical-and-real-world-data-evaluating-efficacy-of-ajovy-fremanezumab-vfrm-injection-presented-at/2024-11-16T00:27:31+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-the-u.s.-launch-of-its-generic-version-of-soolantra-ivermectin-cream-1-for-once-daily2024-11-16T00:27:32+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/new-data-supporting-the-safety-and-efficacy-profile-of-ajovy-fremanezumab-shared-at-7th-european-acade/2024-11-16T00:27:33+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-presents-new-data-at-7th-european-academy-of-neurology-congress-suggesting-socio-economic-factors-ma/2024-11-16T00:27:34+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/new-safety-data-on-treatment-with-copaxone-glatiramer-acetate-of-breastfeeding-mothers-who-live-with-r/2024-11-16T00:27:35+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-its-launch-of-the-first-generic-perforomist-formoterol-fumarate-inhalation-solution-20-/2024-11-16T00:27:36+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-ministry-of-health-labour-and-welfare-approves-ajovy-fremanezumab-injection-in-japan-f/2024-11-16T00:27:37+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-bioeq-announce-commercial-partnership-for-biosimilar/2024-11-16T00:27:38+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-host-conference-call-to-discuss-second-quarter-2021-financial-results-at-8-a.m.-et-on-july-28-202024-11-16T00:27:39+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-changes-to-executive-management-team/2024-11-16T00:27:40+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-second-quarter-2021-financial-results/2024-11-16T00:27:40+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-generic-medicines-saved-the-united-states-$28.8-billion-in-2020-and-a-total-of-$43.1-billion-across2024-11-16T00:27:41+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-ukraine-update/2024-11-16T00:27:42+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-post-hoc-analysis-of-long-term-data-examining-treatment-with-austedo-deutetrabenazine-t/2024-11-16T00:27:43+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/showcasing-tevas-commitment-to-helping-patients-have-more-migraine-free-days-18-abstracts-will-be-prese/2024-11-16T00:27:44+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-medincell-announce-fda-acceptance-of-new-drug-application-for-tv-46000mdc-irm-as-a-treatment-fo/2024-11-16T00:27:45+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/late-breaking-data-at-the-international-headache-society--european-headache-federation-joint-congress-20/2024-11-16T00:27:46+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reaches-agreement-with-louisiana-to-settle-the-states-opioid-related-claims/2024-11-16T00:27:47+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-enlists-sarah-michelle-gellar-to-launch-inhaler-tales-campaign-to-raise-awareness-about-inhaler-us/2024-11-16T00:27:48+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-8-abstracts-on-ajovy-fremanezumab-vfrm-injection-and-hold-symposium-on-healthcare-disp/2024-11-16T00:27:49+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-host-conference-call-to-discuss-third-quarter-2021-financial-results-at-8-a.m.-et-on-october-27-2024-11-16T00:27:50+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/medicine-miles-becoming-a-concern-for-european-patients/2024-11-16T00:27:50+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/new-safety-data-on-treatment-with-copaxone-glatiramer-acetate-of-breastfeeding-mothers-who-live-with-r2/2024-11-16T00:27:51+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-new-data-from-growing-mental-health-portfolio-at-psych-congress-2021/2024-11-16T00:27:52+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-modag-announce-licensing-collaboration-for-neurodegenerative-disease-drug-candidate/2024-11-16T00:27:53+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-third-quarter-2021-financial-results/2024-11-16T00:27:54+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-$4000000000-offering-of-sustainability-linked-senior-notes/2024-11-16T00:27:55+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-$3500000000-debt-tender-offers-for-notes-due-2022-2024/2024-11-16T00:27:56+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/new-phase-3-data-presented-at-psych-congress-2021-showed-tv-46000mdc-irm-significantly-prolonged-time-to/2024-11-16T00:27:57+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/california-judge-rules-that-teva-did-not-cause-a-public-nuisance-or-make-false-or-misleading-statements-a/2024-11-16T00:27:59+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-successful-upsize-of-sustainability-linked-senior-notes-offering-and-pricing-of-$5000000/2024-11-16T00:28:00+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/tevabecomes-first-pharmaceutical-company-to-execute-sustainability-linked-bond-tied-toboth-climate-and-/2025-06-16T09:18:51+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-early-tender-results-of-its-debt-tender-offer-increase-of-the-maximum-tender-amount-and-e/2024-11-16T00:28:01+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-an-authorized-generic-of-epiduo-forte-gel-adapalene-and-benzoyl-peroxide-gel-0/2024-11-16T00:28:02+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-first-to-market-generic-version-of-narcan-naloxone-hydrochloride-nasal-spray/2024-11-16T00:28:03+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-statement-following-new-york-jury-ruling-in-opioids-trial/2024-11-16T00:28:04+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-40th-annual-j.p.-morgan-healthcare-conference2024-11-16T00:28:05+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2021-financial-results-and-2022-fina/2024-11-16T00:28:06+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/research-finds-covid-pandemic-worsened-health-equity-gap/2024-11-16T00:28:07+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reaches-agreement-with-texas-to-settle-the-states-opioid-related-claims/2024-11-16T00:28:08+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-fourth-quarter-and-full-year-2021-financial-results/2024-11-16T00:28:09+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/copaxone-label-now-indicates-its-use-in-breastfeeding-mothers-with-relapsing-multiple-sclerosis/2024-11-16T00:28:10+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-a-first-generic-version-of-revlimid-lenalidomide-capsules-in-the-u.s2024-11-16T00:28:11+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reaches-agreement-with-rhode-island-to-settle-opioid-related-claims/2024-11-16T00:28:11+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reaches-agreement-with-florida-to-settle-the-states-opioid-related-claims/2024-11-16T00:28:13+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-new-analyses-of-ajovy-fremanezumab-vfrm-injection-and-austedo-deutetrabenazine-tabl2/2024-11-16T00:28:14+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-host-conference-call-to-discuss-first-quarter-2022-financial-results-at-8-a.m.-et-on-may-3-20222024-11-16T00:28:15+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-medincell-receive-complete-response-letter-for-tv-46000mdc-irm/2024-11-16T00:28:16+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-settlement-with-lupin-resolving-austedo-deutetrabenazine-patent-dispute/2024-11-16T00:28:17+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-first-quarter-2022-financial-results/2024-11-16T00:28:18+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-publishes-2021-esg-progress-report-showcasing-further-integration-of-esg-into-business-robust-targ/2025-06-13T10:19:27+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-findings-on-short-acting-beta-agonist-saba-use-in-asthma-patients-and-the-potential-of-/2024-11-16T00:28:19+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-new-findings-highlighting-potential-of-proair-digihaler-albuterol-sulfate-inhalation-p/2024-11-16T00:28:20+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-latest-research-from-neurology-portfolio-at-the-2022-american-psychiatric-association-ann/2024-11-16T00:28:21+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/united-kingdom-first-to-grant-licence-for-tevas-ophthalmology-biosimilar-ongavia-ranibizumab/2024-11-16T00:28:22+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-presents-new-long-term-austedo-deutetrabenazine-tablets-data-at-2022-american-psychiatric-associa/2024-11-16T00:28:23+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reaches-agreement-with-west-virginia-to-settle-the-states-opioid-related-claims/2024-11-16T00:28:24+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/direct-relief-the-national-association-of-free-and-charitable-clinics-and-teva-pharmaceuticals-partner-t/2024-11-16T00:28:25+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-latest-data-on-ajovy-fremanezumab-vfrm-injection-at-the-2022-american-headache-society/2024-11-16T00:28:26+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/new-real-world-data-evaluating-ajovy-fremanezumab-vfrm-injection-use-in-patients-with-migraine-present/2024-11-16T00:28:27+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-settlement-with-aurobindo-resolving-austedo-deutetrabenazine-patent-dispute/2024-11-16T00:28:28+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-promising-interim-results-from-its-study-pearl-about-the-impact-of-ajovy-fremanezumab/2024-11-16T00:28:29+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-host-conference-call-to-discuss-second-quarter-2022-financial-results-at-8-a.m.-et-on-july-27-202024-11-16T00:28:30+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-appointment-of-new-global-rd-and-chief-medical-officer/2024-11-16T00:28:31+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reaches-agreement-with-san-francisco-to-settle-opioid-related-claims/2024-11-16T00:28:31+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-second-quarter-2022-financial-results/2024-11-16T00:28:32+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/european-commission-grants-marketing-authorization-for-ranivisio-ranibizumab-a-biosimilar-to-lucent/2024-11-16T00:28:33+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-first-data-set-from-the-connect1-clinical-trial-on-proair-digihaler-albuterol-sulfate/2024-11-16T00:28:34+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/connect1-study-published-in-journal-of-allergy-and-clinical-immunology-in-practice-evaluates-the-potenti/2024-11-16T00:28:35+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/studies-show-effectiveness-of-ajovy-fremanezumab-for-treatment-of-migraine-in-patients-with-co-morbid/2024-11-16T00:28:36+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-launches-honestly-hd-website-to-provide-people-living-with-huntingtons-disease-hd-information-in/2024-11-16T00:28:37+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reaches-agreement-with-georgia-to-settle-the-states-price-fixing-claims/2024-11-16T00:28:37+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-largest-ever-trial-to-collect-information-from-patients-and-physicians-about-td-its-impac/2024-11-16T00:28:38+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-host-conference-call-to-discuss-third-quarter-2022-financial-results-at-8-a.m.-et-on-november-3-2024-11-16T00:28:39+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reaches-agreement-with-arkansas-to-settle-the-states-price-fixing-claims/2024-11-16T00:28:40+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-results-from-3-year-study-assessing-the-safety-and-tolerability-of-austedo-deutetrabenaz/2024-11-16T00:28:41+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/clinics-across-florida-new-jersey--california-advancing-mental-health-in-underserved-communities--awar/2024-11-16T00:28:42+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-third-quarter-2022-financial-results/2024-11-16T00:28:43+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-latest-research-from-the-connect1-and-connect2-clinical-trials-at-the-american-college-of/2024-11-16T00:28:44+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-unique-collaboration-with-healthsnap-to-expand-the-reach-of-its-respiratory-digital-health/2024-11-16T00:28:45+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-unique-collaboration-with-rimidi-to-expand-the-reach-of-its-respiratory-digital-health-pla/2024-11-16T00:28:46+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-appointment-of-richard-francis-as-president-and-ceo/2024-11-16T00:28:47+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-finalizes-nationwide-opioid-settlement-terms/2024-11-16T00:28:48+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-41st-annual-j.p.-morgan-healthcare-conference2024-11-16T00:28:49+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/alvotech-and-teva-announce-acceptance-of-u.s.-biologics-license-application-for-avt04-a-proposed-biosimi2024-11-16T00:28:49+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-nationwide-opioids-settlement-to-move-forward-after-receiving-broad-support-from-states/2024-11-16T00:28:50+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2022-financial-results-and-2023-fina/2024-11-16T00:28:51+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/tevas-ambitious-climate-targets-externally-validated-by-the-science-based-targets-initiative-sbti/2025-06-06T13:48:59+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-fourth-quarter-and-full-year-2022-financial-results/2024-11-16T00:28:53+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reaches-agreement-with-florida-to-settle-the-states-price-fixing-claims/2024-11-16T00:28:54+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-fda-approval-of-austedo-xr-deutetrabenazine-extended-release-tablets-a-new-once-daily-/2024-11-16T00:28:54+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-publication-of-new-clinician-scale-in-journal-of-clinical-psychiatry-to-assess-the-impact-/2024-11-16T00:28:55+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-new-data-from-connect2-study-on-its-digihaler-system-at-the-american-academy-of-allergy/2024-11-16T00:28:56+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-$2060000000-equivalent-offering-of-sustainability-linked-senior-notes/2024-11-16T00:28:57+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-$2250000000-debt-tender-offers-for-notes-due-2023-2026/2024-11-16T00:28:58+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-successful-upsize-and-pricing-of-$2490000000-equivalent-sustainability-linked-senior-/2025-06-26T13:21:34+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-barclays-global-healthcare-conference3/2024-11-16T00:29:00+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-natco-announce-launch-of-additional-strengths-for-the-generic-version-of-revlimid-lenalidomide/2024-11-16T00:29:00+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-early-tender-results-of-its-debt-tender-offer-increases-to-tender-caps-and-election-of-ea/2024-11-16T00:29:01+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/tevas-digital-health-collaboration-with-rimidi-expands-to-include-respiratory-monitoring-program-integra/2024-11-16T00:29:02+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-new-data-on-once-daily-austedo-xr-deutetrabenazine-extended-release-tablets-at-the-202/2024-11-16T00:29:03+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/complete-response-letter-received-for-avt02-biologics-license-application/2024-11-16T00:29:04+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-host-conference-call-to-discuss-first-quarter-2023-financial-results-at-8-a.m.-et-on-may-10-20232024-11-16T00:29:05+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-launch-new-growth-strategy-at-investor-day/2024-11-16T00:29:05+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-medincell-announce-fda-approval-of-uzedy-risperidone-extended-release-injectable-suspension-/2025-10-30T13:27:15+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/u.s.-mental-health-access-program-expands-medicine-donation-to-seven-new-states2024-11-16T00:29:07+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-shares-progress-toward-access-to-medicines-and-environmental-commitments-meeting-and-exceeding-seve/2025-06-16T09:14:10+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-first-quarter-2023-financial-results-and-reaffirms-2023-non-gaap-outlook/2024-11-16T00:29:09+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/austedo-xr-deutetrabenazine-extended-release-tablets-new-once-daily-formulation-of-austedo-now-avai/2024-11-16T00:29:09+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-launches-new-pivot-to-growth-strategy/2025-06-06T13:30:11+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-data-demonstrating-uzedy-risperidone-extended-release-injectable-suspension-significan/2024-11-16T00:29:11+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-presents-real-world-data-for-austedo-deutetrabenazine-tablets-with-4-week-patient-titration-kit-a/2024-11-16T00:29:13+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-concludes-nationwide-opioids-settlement-agreement/2024-11-16T00:29:14+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/alvotech-and-teva-secure-u.s.-license-date-for-avt04-a-proposed-biosimilar-to-stelara2024-11-16T00:29:15+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reaches-agreement-with-kentucky-to-settle-the-states-price-fixing-claims/2024-11-16T00:29:16+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-data-at-the-2023-american-headache-society-annual-scientific-meeting-demonstrating-ajovy/2024-11-16T00:29:17+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/tevas-3rd-interim-analysis-of-pearl-real-world-study-on-ajovy-fremanezumab-reveals-sustained-long-ter/2024-11-16T00:29:18+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-host-conference-call-to-discuss-second-quarter-2023-financial-results-at-8-a.m.-et-on-august-2-22024-11-16T00:29:19+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-pharmaceuticals-and-alvotech-provide-update-on-strategic-biosimilars-partnership/2025-06-26T13:52:21+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-appointment-of-dr.-angus-grant-to-executive-vice-president-business-development2024-11-16T00:29:20+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-second-quarter-2023-financial-results/2025-06-06T13:36:21+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-settles-price-fixing-charges-with-u.s.-doj2024-11-16T00:29:22+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-data-for-austedo-xr-deutetrabenazine-extended-release-tablets-austedo-deutetrabenaz/2024-11-16T00:29:23+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-21st-annual-morgan-stanley-global-healthcare-conference/2024-11-16T00:29:24+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-changes-to-executive-management-team2/2024-11-16T00:29:24+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/sanofi-and-teva-announce-exclusive-collaboration-to-deliver-inflammatory-bowel-disease-treatment/2025-06-26T13:34:00+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-host-conference-call-to-discuss-third-quarter-2023-financial-results-at-8-a.m.-et-on-november-8-2024-11-16T00:29:27+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-phase-iv-unite-study-shows-ajovy-fremanezumab-reduced-migraine-attacks-and-depression-symptoms-in/2024-11-16T00:29:28+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-provide-second-round-of-funding-to-clinics-in-california-florida-and-new-jersey-as-part-of-$2-mi/2024-11-16T00:29:30+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/uzedy-risperidone-extended-release-injectable-suspension-significantly-prolongs-time-to-schizophrenia-/2024-11-16T00:29:31+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-new-data-supporting-safety-efficacy-and-real-world-effectiveness-of-austedo-deutetrabe/2024-11-16T00:29:32+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-appoints-new-ceo-for-teva-api-its-active-pharmaceutical-ingredients-business/2024-11-16T00:29:33+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-third-quarter-2023-financial-results-and-increases-revenue-guidance/2025-06-16T09:13:18+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-royalty-pharma-collaborate-to-further-accelerate-olanzapine-lai-program/2025-06-26T13:47:29+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-approval-of-a-generic-version-of-forteo-teriparatide-injection-in-the-u.s2024-11-16T00:29:36+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-6th-annual-evercore-isi-healthconx-conference/2024-11-16T00:29:37+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-completes-closing-of-exclusive-collaboration-deal-to-deliver-inflammatory-bowel-disease-treatment/2024-11-16T00:29:38+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/new-post-hoc-phase-3-data-analysis-shows-ajovy-fremanezumab-reduced-migraine-attacks-in-adults-with-mi/2024-11-16T00:29:39+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-biolojic-design-announce-exclusive-license-agreement-for-the-development-of-a-therapeutic-antibo/2025-06-26T13:45:35+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-42nd-annual-j.p.-morgan-healthcare-conference2024-11-16T00:29:41+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2023-financial-results-and-2024-fina/2024-11-16T00:29:42+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-intention-to-divest-api-business-as-part-of-pivot-to-growth-strategy/2024-11-16T00:29:43+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-growth-in-fourth-quarter-and-full-year-2023/2025-06-06T13:35:00+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-presents-new-data-supporting-safety-tolerability-and-target-engagement-of-anti-tl1a-tev-574-anti/2024-11-16T00:29:45+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/alvotech-and-teva-announce-u.s.-approval-of-simlandi-adalimumab-ryvk-injection-the-first-interchangea2024-11-16T00:29:46+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-jiangsu-nhwa-forge-strategic-partnership-to-promote-patient-access-to-austedo-in-china/2024-11-16T00:29:47+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/clinical-collaboration-agreement-between-teva-and-launch-therapeutics-to-accelerate-development-of-dual-a/2024-11-16T00:29:48+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-mabxience-announce-strategic-global-licensing-agreement-for-oncology-biosimilar-candidate/2024-11-16T00:29:49+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/new-pharmacokinetic-modeling-data-presented-by-teva-simulates-clinical-profiles-of-schizophrenia-patients/2024-11-16T00:29:50+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-host-conference-call-to-discuss-first-quarter-2024-financial-results-at-8-a.m.-et-on-may-8-20242024-11-16T00:29:51+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-confirms-efficacy-and-safety-of-ajovy-fremanezumab-for-the-prevention-of-migraine-with-results-fr/2024-11-16T00:29:51+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/tevas-new-real-world-evidence-presented-at-the-2024-aan-annual-meeting-confirms-effectiveness-and-patien/2024-11-16T00:29:52+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/alvotech-and-teva-announce-u.s.-fda-approval-of-selarsdi-ustekinumab-aekn-biosimilar-to-stelara-ust2024-11-16T00:29:53+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/u.s.-commercialization-agreement-with-quallent-to-drive-patient-savings-with-first-high-concentration-cit2024-11-16T00:29:54+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/tevas-2023-healthy-future-report-showcases-renewed-sustainability-strategy-and-ambitious-targets/2025-06-16T09:20:19+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-2024-bank-of-america-healthcare-conference/2024-11-16T00:29:56+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-medincell-announce-positive-phase-3-efficacy-results-from-solaris-trial-evaluating-tev-749-ola/2024-11-16T00:29:58+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reports-first-quarter-2024-financial-results-and-reaffirms-2024-financial-outlook/2025-06-13T10:18:36+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-appointment-of-matthew-shields-to-executive-vice-president-teva-global-operations/2024-11-16T00:30:00+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-alvotech-announce-simlandi-adalimumab-ryvk-injection-now-available-in-the-u.s2024-11-16T00:30:01+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-austedo-xr-deutetrabenazine-extended-release-tablets-now-u.s.-fda-approved-as-a-one-pil2024-11-16T00:30:02+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/new-data-provide-schizophrenia-treatment-insights-into-switching-to-uzedy-risperidone-extended-release/2024-11-16T00:30:03+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-presents-first-real-world-data-from-the-impact-td-registry-study-at-psych-congress-elevate-2024/2024-11-16T00:30:03+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-goldman-sachs-45th-annual-global-healthcare-conference/2024-11-16T00:30:04+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-authorized-generic-of-victoza-liraglutide-injection-1.8mg-in-the-united-stat2024-11-16T00:30:05+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-reaches-agreement-with-the-israel-tax-authority-to-resolve-all-pending-litigation-for-the-companys-/2024-11-16T00:30:06+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/new-ajovy-fremanezumab-migraine-prevention-data-challenges-treatment-pauses/2024-11-16T00:30:07+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-host-conference-call-to-discuss-second-quarter-2024-financial-results-at-8-a.m.-et-on-july-31-202024-11-16T00:30:08+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-first-phase-3-evidence-of-efficacy-and-safety-of-an-anti-cgrp-monoclonal-antibody-in-child/2025-10-30T13:35:50+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-sanofi-announce-accelerated-timeline-for-anti-tl1a-phase-2b-program-in-patients-with-inflammator/2024-11-16T00:30:09+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-strong-growth-in-second-quarter-revenues-mainly-driven-by-generics-products-in-all-regions-and-austedo-raises-2024-financial-guidance/2024-11-16T00:30:10+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-morgan-stanley-22nd-annual-global-healthcare-conference/2024-11-16T00:30:11+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-present-at-the-bank-of-america-2024-global-healthcare-conference/2024-11-16T00:30:12+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/new-data-provide-treatment-insights-into-options-for-switching-adult-patients-diagnosed-with-schizophreni/2024-11-16T00:30:13+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-presents-new-phase-3-efficacy-safety-and-tolerability-data-from-solaris-trial-evaluating-tev-749-/2024-11-16T00:30:14+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-long-term-efficacy-and-safety-of-deutetrabenazine-in-european-patients-with-debilitating-m/2024-11-16T00:30:15+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-to-host-conference-call-to-discuss-third-quarter-2024-financial-results-at-8-a.m.-et-on-november-6-2024-11-16T00:30:16+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-the-first-and-only-generic-version-of-sandostatin-lar-depot-octreotide-acetate/2024-11-16T00:30:17+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-and-mabxience-expand-strategic-partnership-to-include-an-additional-oncology-biosimilar-candidate/2024-11-16T00:30:18+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-prolia-denosumab-biosimilar-candidate-is-accepted-for-reviewby-u.s.-fda-and-eu-ema2024-11-16T00:30:19+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/alvotech-and-teva-announce-u.s.-fda-approval-of-additional-presentation-of-selarsdi-ustekinumab-aekn-2024-11-16T00:30:20+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-statement-on-european-commission-decision-company-to-appeal/2024-11-16T00:30:21+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-presents-latest-schizophrenia-treatment-research-including-phase-3-solaris-trial-results-demonstrat/2024-11-16T00:30:22+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-presents-new-tardive-dyskinesia-data-at-psych-congress-2024-from-the-impact-td-registry-revealing-d/2024-11-16T00:30:23+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/teva-announces-strong-financial-results-for-the-third-quarter-of-2024-led-by-generics-performance-and-in/2025-06-26T13:51:46+00:00monthly0.5https://www.tevapharm.com/news-and-media/teva-russia-update/2024-11-16T00:30:33+00:00monthly0.5https://www.tevapharm.com/news-and-media/teva-social-media-guidelines/2025-07-17T09:28:07+00:00monthly0.5https://www.tevapharm.com/news-and-media/latest-news/2025-10-29T08:54:32+00:00yearly0.5https://www.tevapharm.com/our-company/our-values/2025-07-17T09:01:51+00:00weekly0.5https://www.tevapharm.com/our-company/teva-history/2025-07-17T08:58:48+00:00monthly0.5https://www.tevapharm.com/our-company/corporate-governance/2025-07-17T09:03:07+00:00yearly0.5https://www.tevapharm.com/our-company/supply-chain/2025-07-17T09:00:31+00:00monthly0.5https://www.tevapharm.com/our-company/our-purpose/2025-11-11T13:00:44+00:00weekly0.5https://www.tevapharm.com/patients-and-caregivers/patient-safety/2025-07-17T07:37:14+00:00monthly0.5https://www.tevapharm.com/product-focus/consumer-healthcare/2025-07-17T07:32:17+00:00weekly0.5https://www.tevapharm.com/product-focus/medis/2025-06-16T09:34:52+00:00monthly0.5https://www.tevapharm.com/product-focus/generics/2025-07-17T07:49:00+00:00monthly0.5https://www.tevapharm.com/product-focus/our-quality/2025-07-17T07:20:57+00:00monthly0.5https://www.tevapharm.com/science/iss-collaborative-research/2025-10-30T13:20:34+00:00weekly0.5https://www.tevapharm.com/news-and-media/feature-stories/2025-10-29T08:43:19+00:00weekly0.5https://www.tevapharm.com/your-career/what-we-do-at-teva/2025-07-17T06:50:38+00:00monthly0.5https://www.tevapharm.com/your-career/inclusion-and-diversity-at-teva/2025-07-17T06:57:55+00:00monthly0.5https://www.tevapharm.com/your-career/life-at-teva/2025-07-17T06:52:44+00:00monthly0.5https://www.tevapharm.com/your-career/growth-at-teva/2025-07-17T06:59:34+00:00monthly0.5https://www.tevapharm.com/your-career/benefits-wellbeing/2025-07-17T07:02:50+00:00monthly0.5https://www.tevapharm.com/your-career/changing-industry/2025-07-17T07:02:14+00:00weekly0.5https://www.tevapharm.com/your-career/how-we-hire/2025-07-17T06:58:43+00:00monthly0.5https://www.tevapharm.com/your-career/our-people/2025-07-17T07:06:19+00:00weekly0.5https://www.tevapharm.com/teva-clinical-trials/compassionate-use-programs/2025-07-17T07:01:57+00:00monthly0.5https://www.tevapharm.com/teva-clinical-trials/faq/2025-07-17T07:03:39+00:00monthly0.5https://www.tevapharm.com/teva-clinical-trials/iqualifyceliac-form/2025-06-05T06:16:11+00:00monthly0.5https://www.tevapharm.com/teva-clinical-trials/fpa-as-30094-participate/2025-06-05T06:16:12+00:00monthly0.5https://www.tevapharm.com/teva-clinical-trials/clinical-development/2025-07-17T06:59:49+00:00weekly0.5https://www.tevapharm.com/teva-clinical-trials/c109539022-participate/2025-08-14T13:16:14+00:00monthly0.5https://www.tevapharm.com/teva-clinical-trials/tv48125-cns-30084-participate/2025-08-14T13:16:03+00:00monthly0.5https://www.tevapharm.com/teva-clinical-trials/tv48125-cns-30082-participate/2025-08-14T13:15:54+00:00monthly0.5https://www.tevapharm.com/teva-clinical-trials/tv48125-cns-30083-participate/2025-08-14T13:15:45+00:00monthly0.5https://www.tevapharm.com/teva-clinical-trials/TV50717-CNS-30081-participate/2025-08-14T13:15:22+00:00monthly0.5https://www.tevapharm.com/teva-clinical-trials/tv48125-cns-30088-participate/2025-08-14T13:14:57+00:00monthly0.5https://www.tevapharm.com/teva-clinical-trials/tv44749-cns-30096-participate/2025-08-14T13:14:49+00:00monthly0.5https://www.tevapharm.com/teva-clinical-trials/tv48574-imm-20036-participate/2025-08-14T13:14:38+00:00monthly0.5https://www.tevapharm.com/teva-clinical-trials/tv48574-imm-20038-participate/2025-08-14T13:14:29+00:00monthly0.5https://www.tevapharm.com/teva-clinical-trials/transparency-of-clinical-study-results/2025-07-17T07:05:07+00:00monthly0.5https://www.tevapharm.com/teva-clinical-trials/data-requests/2025-07-17T07:03:00+00:00monthly0.5https://www.tevapharm.com/teva-clinical-trials/for-patients/2025-08-14T13:39:21+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/humanizing-health/2025-11-21T08:56:55+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/contributors-lobby/2025-08-18T06:34:26+00:00monthly0.5https://www.tevapharm.com/teva-medical-information/countries-consent/2025-07-17T07:30:54+00:00monthly0.5https://www.tevapharm.com/your-career/pride-teva/2025-07-17T06:54:56+00:00monthly0.5https://www.tevapharm.com/your-career/iwd-tevapharm-2023/2024-11-17T15:30:34+00:00monthly0.5https://www.tevapharm.com/your-career/gender-equality/2025-07-17T07:01:01+00:00monthly0.5https://www.tevapharm.com/teva-medical-information/msl-form/2025-07-17T07:33:11+00:00monthly0.5https://www.tevapharm.com/teva-medical-information/medinfo-form/2025-07-17T07:29:24+00:00monthly0.5https://www.tevapharm.com/teva-medical-information/product-quality-complaint-form/2025-07-17T07:33:32+00:00monthly0.5https://www.tevapharm.com/our-impact/global-patient-advocacy-engagement/2025-05-27T07:38:55+00:00monthly0.5https://www.tevapharm.com/our-impact/previous-reports/2025-07-17T08:51:07+00:00yearly0.5https://www.tevapharm.com/our-impact/contributing-healthy-communities/2025-07-17T08:48:27+00:00monthly0.5https://www.tevapharm.com/our-impact/multiple-chronic-conditions/2024-11-25T09:07:33+00:00yearly0.5https://www.tevapharm.com/our-impact/esg-progress-report-2019/2025-05-27T07:35:16+00:00yearly0.5https://www.tevapharm.com/our-impact/esg-progress-report-2021/2025-07-17T08:57:22+00:00yearly0.5https://www.tevapharm.com/our-impact/caring-for-our-employees/2025-07-17T08:49:05+00:00monthly0.5https://www.tevapharm.com/our-impact/maintaining-responsible-supply-chain/2025-07-17T08:44:37+00:00monthly0.5https://www.tevapharm.com/our-impact/giving-back-to-our-communities/2025-07-17T08:46:54+00:00monthly0.5https://www.tevapharm.com/our-impact/providing-medicines-people-can-trust/2025-07-17T08:41:45+00:00monthly0.5https://www.tevapharm.com/our-impact/sustainable-development/2025-07-17T08:41:10+00:00monthly0.5https://www.tevapharm.com/our-impact/teva-maintaining-an-ethical-and-compliant-business/2025-07-17T08:40:52+00:00monthly0.5https://www.tevapharm.com/our-impact/esg-progress-report-2020/2025-07-17T08:57:50+00:00yearly0.5https://www.tevapharm.com/our-impact/addressing-antimicrobial-resistance/2025-05-26T07:00:57+00:00monthly0.5https://www.tevapharm.com/our-impact/esg-progress-report-2022/2024-11-22T13:51:14+00:00monthly0.5https://www.tevapharm.com/our-impact/doing-business-the-right-way/2025-07-17T08:47:32+00:00monthly0.5https://www.tevapharm.com/our-impact/economic-impact-report/2025-05-26T07:03:35+00:00monthly0.5https://www.tevapharm.com/patients-and-caregivers/all-stories/2025-10-20T10:54:40+00:00monthly0.5https://www.tevapharm.com/our-impact/introducing-healthy-future-a-stronger-bolder-and-simpler-approach-to-sustainability/2025-07-17T08:44:05+00:00monthly0.5https://www.tevapharm.com/our-impact/healthy-future-report/2025-07-17T08:55:19+00:00weekly0.5https://www.tevapharm.com/teva-in-europe/making-medicines-in-europe/2025-07-17T07:11:42+00:00weekly0.5https://www.tevapharm.com/teva-in-europe/providing-access-to-medicines-for-millions-of-patients-across-europe/2025-07-17T07:09:08+00:00weekly0.5https://www.tevapharm.com/teva-in-europe/manufacturing-resilience/2025-07-17T07:10:26+00:00monthly0.5https://www.tevapharm.com/teva-clinical-trials/clinical-trials-results/2025-07-17T06:55:07+00:00weekly0.5https://www.tevapharm.com/science/pipeline/2025-07-17T07:35:29+00:00weekly0.5https://www.tevapharm.com/your-career/accessibility/2025-11-09T08:07:59+00:00monthly0.5https://www.tevapharm.com/your-career/applicant-security-disclaimer/2025-11-09T08:03:40+00:00monthly0.5https://www.tevapharm.com/your-career/job-application-support/2025-04-29T13:13:35+00:00monthly0.5https://www.tevapharm.com/product-focus/teva-biosimilars/2025-05-29T07:33:01+00:00weekly0.5https://www.tevapharm.com/product-focus/generic-medicines/2025-07-17T07:50:34+00:00yearly0.5https://www.tevapharm.com/science/innovative-therapeutic-areas/2025-10-29T16:10:08+00:00monthly0.5https://www.tevapharm.com/our-impact/healthy-future-report-2023/2025-05-14T11:11:35+00:00monthly0.5https://www.tevapharm.com/teva-in-europe/teva-in-neuroscience/2025-11-17T10:50:29+00:00monthly0.5https://www.tevapharm.com/teva-medical-information/report-a-side-effect-form/2025-07-17T07:34:18+00:00monthly0.5https://www.tevapharm.com/daily-news/search-results/2025-07-03T08:10:48+00:00yearly0.5https://www.tevapharm.com/science/2025-07-17T07:39:58+00:00weekly0.5https://www.tevapharm.com/teva-worldwide-locations/2025-11-20T08:31:59+00:00weekly0.5https://www.tevapharm.com/what-are-biologics/2024-11-17T15:23:38+00:00monthly0.5https://www.tevapharm.com/our-company/2025-07-17T08:59:33+00:00weekly0.5https://www.tevapharm.com/patients-and-caregivers/2025-07-17T07:57:33+00:00monthly0.5https://www.tevapharm.com/teva-in-europe/2025-07-17T07:13:09+00:00weekly0.5https://www.tevapharm.com/teva-medical-information/2025-07-17T07:30:25+00:00monthly0.5https://www.tevapharm.com/your-career/2025-07-17T07:03:35+00:00yearly0.5https://www.tevapharm.com/teva-corporate-video/2025-10-29T16:57:25+00:00monthly0.5https://www.tevapharm.com/sitemap-page/2025-11-16T20:02:39+00:00monthly0.5https://www.tevapharm.com/our-impact/2025-07-17T08:49:29+00:00monthly0.5https://www.tevapharm.com/teva-clinical-trials/2025-07-17T06:59:09+00:00monthly0.5https://www.tevapharm.com/news-and-media/2025-07-17T09:28:32+00:00monthly0.5https://www.tevapharm.com/product-focus/2025-07-17T07:32:53+00:00yearly0.5https://www.tevapharm.com/error-404/2025-10-29T16:19:03+00:00monthly0.5https://www.tevapharm.com/ir/2025-07-17T07:10:57+00:00yearly0.5https://www.tevapharm.com/contact-us/2025-07-17T07:05:59+00:00yearly0.5https://www.tevapharm.com/search-results/2025-11-12T09:28:42+00:00monthly0.5